骨桥蛋白在胆囊胆固醇结石形成中的作用及相关机制研究
|
摘要
第一部分骨桥蛋白在不同体外模拟胆汁体系中成核作用的综合研究
目的探讨骨桥蛋白(OPN)在Small模拟胆汁和综合模拟胆汁中的成核效应及其可能的相关机制。方法制备过饱和Small模拟胆汁和综合模拟胆汁,分别用成核时间实验、胆固醇结晶生长实验探讨OPN在体外模拟胆汁中的成核效应。制备Small模拟胆汁通过电镜负染技术研究OPN对胆汁中胆固醇-磷脂泡融合聚集过程的动态影响。结果在Small模拟胆汁和综合模拟胆汁中OPN可显著延缓胆固醇结晶的成核时间,且其抑成核效应表现为剂量依赖性。钙离子表现为促成核效应,其效应被OPN抑制。OPN既可增加胆固醇结晶的成核时间指数,又可降低胆固醇结晶的生长指数,而钙离子仅降低胆固醇结晶的成核时间指数,不影响胆固醇结晶生长。电镜研究提示OPN使模拟胆汁中的胆汁泡结构更加稳定,并抑制胆汁泡的融合、聚集和进展。结论OPN在模拟胆汁中具有抑成核活性,其效应和钙离子相关,OPN可能通过抑制胆固醇结晶成核、结晶生长及稳定胆汁泡等作用起到抑制胆囊胆固醇结石形成的作用。
第二部分OPN在人胆囊胆汁中的表达及成核作用研究
目的研究OPN在人胆囊胆汁中的成核作用,探讨OPN及脂质成分在结石胆汁和对照胆汁中的分布差异。方法利用Holan成核时间实验研究OPN在胆固醇结石患者胆囊胆汁和对照组胆囊胆汁中的成核作用；超速离心技术制备均相胆汁,磷钨酸负染/电镜观察研究OPN对胆囊胆汁中胆汁泡的影响；ELISA检测OPN及胆汁脂质分子在胆汁中的分布差别。结果在结石患者胆囊胆汁和对照组胆汁中OPN均可使胆固醇成核时间显著延长,并呈剂量依赖性,其抑成核效应表现在生理浓度区。钙离子可使成核时间显著缩短,促进成核,但其促成核效应被OPN抑制。通过电镜扫描观察发现OPN可抑制人胆囊胆汁中胆汁泡的出现、融合聚集过程,从而抑制胆固醇结晶析出、沉淀。结石患者胆囊胆汁中OPN和钙离子低于对照组胆汁中含量(P<0.05),而胆固醇、磷脂、胆酸和CSI则高于对照组胆汁(P<0.05)。结论OPN在人胆囊胆汁具有同模拟胆汁相似的抑成核效应,OPN可能通过抑制胆固醇结晶的出现、胆汁泡进展等步骤影响结石形成,为进一步研究其具体机制提供了基础。
第三部分OPN及其受体在胆囊胆固醇结石形成中表达机制的初步研究
目的研究OPN及受体integriαv、CD44在胆固醇结石胆囊组织中的表达及作用,检测胆汁及外周血中OPN含量变化的一致性。方法免疫组织化学技术验证OPN、integrinαv和CD44在结石胆囊组织(分两组,结石组Ⅰ：胆囊组织相对正常,无胆囊组织纤维化；病变组Ⅱ：胆囊组织内皮有剥落、破坏,胆囊壁有纤维化改变)和正常对照胆囊组织中的差异表达。RT-PCR及Western Blot验证其在mRNA和蛋白质水平的变化。ELISA检测外周血OPN表达。结果免疫组织化学结果显示OPN及其受体integrinαv、CD44的免疫染色在病变组Ⅰ较对照组增高；而在病变组Ⅱ,OPN及integrinαv、CD44的免疫染色明显降低。RT-PCR及Western Blot结果表明OPN及受体integrinαv、CD44在mRNA水平和蛋白质水平的表达与免疫组织化学染色结果一致。ELISA检测发现结石患者外周血中OPN含量低于对照组,与胆汁中OPN含量变化具有一致性。结论免疫组织化学和RT-PCR、Western Blot对OPN及及integrinαv、CD44的检测结果表明OPN在胆囊胆固醇结石过程中是动态变化的,其作用可能是通过与integrinαv、CD44的结合来实现的。OPN可能作为一个潜在的外周血标志因子。
第四部分OPN在胆囊胆固醇结石形成中的动态机制研究
目的探讨OPN在胆囊胆固醇结石形成中的变化机制,及其他促／抑成核因子在胆汁和血液中的动态改变。方法RT-PCR检测胆囊组织和肝脏组织中OPN mRNA在豚鼠胆囊胆固醇结石形成过程中的动态改变,ELISA检测OPN及其他相关因子在胆汁和血液中的变化。结果成功建立豚鼠胆囊胆固醇结石动物模型,与对照组相比,OPN mRNA在豚鼠胆囊组织和肝脏组织中的表达逐渐增高,至第6周到高峰,随后逐渐下降。而ELISA发现OPN在胆汁中表达也是逐渐增高,第6周达高峰,随后逐渐下降,呈峰型分布,其在血液中的变化与胆汁中表现一致,但OPN峰值改变早于胆汁。抑成核因子载脂蛋白AI在胆汁和血液中的变化与OPN类似。而促成核因子粘蛋白和α1-酸性糖蛋白在胆汁和血液中逐渐升高,并一直维持高水平而不下降。结论肝脏和胆囊的功能参与调节OPN在胆囊胆固醇结石形成中的作用,OPN等抑成核因子的动态变化和促成核因子不同,提示胆汁中促/抑成核平衡的变化在胆结石形成中起重要作用。
本课题通过体外胆汁的成核相关实验技术表明OPN具有抑制胆囊胆固醇结石形成的作用,其抑成核效应和钙离子相关,并呈剂量依赖性。通过人体标本试验表明OPN在人胆囊胆固醇结石中同样具有抑成核效应,OPN在结石患者中作用可能是通过与其受体结合实现的。并进一步通过动物模型试验揭示OPN在胆囊胆固醇结石形成过程中的动态变化机制及其他相关成核相关因子的变化机制。初步探讨了促成核因子和抑成核因子在结石胆汁中的变化作用,为进一步阐明促/抑成核平衡在胆结石形成中的机制提供了一定基础。
Part one The synthetic study of the nucleation role of osteopontin in different model bile systems in vitro
Objective To investigate the nucleation role and the related mechanisms of osteopontin (OPN) in Small and Synthetic model bile systems in vitro. Methods The Small and Synthetic model bile systems have been prepared according the previously described methods, then the nucleation time assay and cholesterol crystal growth assay have been used to determine the nucleation role of the osteopontin in vitro. The effect of OPN on cholesterol-phosphalipids vesicles have been studied by the negative staining under the electron microscopy. Results OPN prolonged the nucleation time in Small and Synthetic model bile in vitro, this anti-nucleation role showed the dose dependent manner. While the calcium showed the pro-nucleation role in model bile, but this role was inhibited by OPN. Cholesterol crystal growth was inhibited by OPN in a dose dependent manner, but not affected by calcium. Furthermore, the formation, aggregation and fusion of vesicles were suppressed by OPN in model bile as demonstrated by transmission electron microscopy, and the vesicles were stabilized by OPN. Conclusions OPN played the anti-nucleation role in model bile systems and this role correlated with the calcium. These findings indicated OPN could inhibit the cholesterol gallstone formation by inhibiting cholesterol crystal nucleation, growth and stabilizing vesicles in model bile.
Part two The expression and nucleation role of OPN in human gallbladder bile
Objective To study the nucleation role of OPN in human gallbladder bile, and the concentrations of OPN and biliary lipids in lithogenic bile and control bile. Methods Nucleation role was determined in lithogenic bile and control bile in vitro. Effect of OPN on vesicles of bile was investigated via transmission electron microscopy. OPN and biliary lipids compositions in both gallbladder biles were determined via commercial kits. Results OPN prolonged nucleation time both in lithogenic gallbladder bile and control bile in vitro, this anti-nucleation role showed the dose dependent manner and played the effect at the physical concentration level. Calcium ions shortened nucleation time, but this effect was inhibited by OPN. Furthermore, the formation, aggregation and fusion of cholesterol-phospholipid vesicles were inhibited by OPN in human bile. The concentration of cholesterol, phospholipid, bile acids, and CSI were higher in lithogenic gallbladder bile than in normal gallbladder bile (P＜0.05); the contents of OPN and calcium, nevertheless, were found to be lower in lithogenic bile than those in normal controls. Conclusions OPN played the similar anti-nucleation role in human gallbladder bile as in model bile, which might inhibited the onset of the cholesterol crystal and the dynamic change of vesicles in human bile. These data might be a basis for further investigating the exact mechanism of OPN in the formation of cholesterol gallstone.
Part three Preliminary research of the expression menchanism of OPN and its receptors in cholesterol gallstone formation
Objective To investigate the expression of OPN and its receptors (integrin av, CD44) in cholesterol gallstone formation, and determine the OPN content in peripheral blood. Methods The immunostaining, mRNA and protein of OPN, integrin av and CD44 were analyzed in human lithogenic gallbladder tissue (case group I, with normal epithelia; case groupⅡ, with degenerated epithelia and fibrosis) and normal tissue. OPN content was detected by the ELISA kits. Results The immunostaining for OPN, integrin av and CD44 in human gallbladder tissues showed a higher reactivity in case groupⅠthan the control group, and in case group II, the immunostaining showed a lower reactivity. The mRNA and protein level of OPN, integrin av and CD44 in gallstone gallbladder tissue showed the similar results with the immunostaining assay in human gallbladder tissue. OPN content in blood showed the similar trend with that in gallbladder bile. Conclusions These data demonstrated that OPN, integrin av and CD44 were involved in gallstone formation as the dynamic change, the effect of OPN might be regulated by its receptors, OPN might be a potential blood marker molecule in gallstone formation.
Part Four Preliminary investigation of the dynamic changes of OPN in cholesterol gallstone formation
Objective To examine the dynamic expression of OPN in cholesterol gallstone formation, and the contents of OPN and other factors in gallbladder bile and blood. Methods Expression of OPN mRNA were detected by RT-PCR in gallbladder and hepatic tissues of cholesterol gallstone formation in guinea pig, contents of OPN and other factors in bile and blood were detected by ELISA kits. Results The lithogenic model have been established successfully in guinea pig. OPN mRNA expression in gallbladder and hepatic tissues were gradually increased and reached to the peak at the sixth week in lithogenic diet fed group, then decreased after six week. The contents of OPN in gallbladder bile and blood showed the similar results, but the peak value of OPN in blood was examined early than that in bile. The other anti-nucleation factor, apoprotein AI showed the similar results with OPN. However, pro-nucleation factors, mucin and AAP showed the increased value in bile and blood, which did not show the descended curve. Conclusions Function of gallbladder and liver might be involved in the anti-nucleation role of OPN, the differential changes of pro-nucleation and anti-nucleation factors in bile might played the important role in cholesterol gallstone formation.
In conclusion, the results suggested that OPN played an anti-nucleation role in cholesterol gallstone formation in vitro as the nucleation assays in model bile, and the role of OPN correlated with calcium and showed the dose dependent manner. Then it is found that the OPN showed the similar anti-nucleation role in human bile, and the role of OPN might be regulated by its receptors. Furthermore, the dynamic mechanism of OPN in the process of gallstone formation was determined via the guinea pig lithogenic model. We detected the dynamic role of the pro-nucleation and anti-nucleation factors in gallstone formation, and the possible mechanism of the nucleation equilibrium in cholesterol gallstone formation.
目的探讨骨桥蛋白(OPN)在Small模拟胆汁和综合模拟胆汁中的成核效应及其可能的相关机制。方法制备过饱和Small模拟胆汁和综合模拟胆汁,分别用成核时间实验、胆固醇结晶生长实验探讨OPN在体外模拟胆汁中的成核效应。制备Small模拟胆汁通过电镜负染技术研究OPN对胆汁中胆固醇-磷脂泡融合聚集过程的动态影响。结果在Small模拟胆汁和综合模拟胆汁中OPN可显著延缓胆固醇结晶的成核时间,且其抑成核效应表现为剂量依赖性。钙离子表现为促成核效应,其效应被OPN抑制。OPN既可增加胆固醇结晶的成核时间指数,又可降低胆固醇结晶的生长指数,而钙离子仅降低胆固醇结晶的成核时间指数,不影响胆固醇结晶生长。电镜研究提示OPN使模拟胆汁中的胆汁泡结构更加稳定,并抑制胆汁泡的融合、聚集和进展。结论OPN在模拟胆汁中具有抑成核活性,其效应和钙离子相关,OPN可能通过抑制胆固醇结晶成核、结晶生长及稳定胆汁泡等作用起到抑制胆囊胆固醇结石形成的作用。
第二部分OPN在人胆囊胆汁中的表达及成核作用研究
目的研究OPN在人胆囊胆汁中的成核作用,探讨OPN及脂质成分在结石胆汁和对照胆汁中的分布差异。方法利用Holan成核时间实验研究OPN在胆固醇结石患者胆囊胆汁和对照组胆囊胆汁中的成核作用；超速离心技术制备均相胆汁,磷钨酸负染/电镜观察研究OPN对胆囊胆汁中胆汁泡的影响；ELISA检测OPN及胆汁脂质分子在胆汁中的分布差别。结果在结石患者胆囊胆汁和对照组胆汁中OPN均可使胆固醇成核时间显著延长,并呈剂量依赖性,其抑成核效应表现在生理浓度区。钙离子可使成核时间显著缩短,促进成核,但其促成核效应被OPN抑制。通过电镜扫描观察发现OPN可抑制人胆囊胆汁中胆汁泡的出现、融合聚集过程,从而抑制胆固醇结晶析出、沉淀。结石患者胆囊胆汁中OPN和钙离子低于对照组胆汁中含量(P<0.05),而胆固醇、磷脂、胆酸和CSI则高于对照组胆汁(P<0.05)。结论OPN在人胆囊胆汁具有同模拟胆汁相似的抑成核效应,OPN可能通过抑制胆固醇结晶的出现、胆汁泡进展等步骤影响结石形成,为进一步研究其具体机制提供了基础。
第三部分OPN及其受体在胆囊胆固醇结石形成中表达机制的初步研究
目的研究OPN及受体integriαv、CD44在胆固醇结石胆囊组织中的表达及作用,检测胆汁及外周血中OPN含量变化的一致性。方法免疫组织化学技术验证OPN、integrinαv和CD44在结石胆囊组织(分两组,结石组Ⅰ：胆囊组织相对正常,无胆囊组织纤维化；病变组Ⅱ：胆囊组织内皮有剥落、破坏,胆囊壁有纤维化改变)和正常对照胆囊组织中的差异表达。RT-PCR及Western Blot验证其在mRNA和蛋白质水平的变化。ELISA检测外周血OPN表达。结果免疫组织化学结果显示OPN及其受体integrinαv、CD44的免疫染色在病变组Ⅰ较对照组增高；而在病变组Ⅱ,OPN及integrinαv、CD44的免疫染色明显降低。RT-PCR及Western Blot结果表明OPN及受体integrinαv、CD44在mRNA水平和蛋白质水平的表达与免疫组织化学染色结果一致。ELISA检测发现结石患者外周血中OPN含量低于对照组,与胆汁中OPN含量变化具有一致性。结论免疫组织化学和RT-PCR、Western Blot对OPN及及integrinαv、CD44的检测结果表明OPN在胆囊胆固醇结石过程中是动态变化的,其作用可能是通过与integrinαv、CD44的结合来实现的。OPN可能作为一个潜在的外周血标志因子。
第四部分OPN在胆囊胆固醇结石形成中的动态机制研究
目的探讨OPN在胆囊胆固醇结石形成中的变化机制,及其他促／抑成核因子在胆汁和血液中的动态改变。方法RT-PCR检测胆囊组织和肝脏组织中OPN mRNA在豚鼠胆囊胆固醇结石形成过程中的动态改变,ELISA检测OPN及其他相关因子在胆汁和血液中的变化。结果成功建立豚鼠胆囊胆固醇结石动物模型,与对照组相比,OPN mRNA在豚鼠胆囊组织和肝脏组织中的表达逐渐增高,至第6周到高峰,随后逐渐下降。而ELISA发现OPN在胆汁中表达也是逐渐增高,第6周达高峰,随后逐渐下降,呈峰型分布,其在血液中的变化与胆汁中表现一致,但OPN峰值改变早于胆汁。抑成核因子载脂蛋白AI在胆汁和血液中的变化与OPN类似。而促成核因子粘蛋白和α1-酸性糖蛋白在胆汁和血液中逐渐升高,并一直维持高水平而不下降。结论肝脏和胆囊的功能参与调节OPN在胆囊胆固醇结石形成中的作用,OPN等抑成核因子的动态变化和促成核因子不同,提示胆汁中促/抑成核平衡的变化在胆结石形成中起重要作用。
本课题通过体外胆汁的成核相关实验技术表明OPN具有抑制胆囊胆固醇结石形成的作用,其抑成核效应和钙离子相关,并呈剂量依赖性。通过人体标本试验表明OPN在人胆囊胆固醇结石中同样具有抑成核效应,OPN在结石患者中作用可能是通过与其受体结合实现的。并进一步通过动物模型试验揭示OPN在胆囊胆固醇结石形成过程中的动态变化机制及其他相关成核相关因子的变化机制。初步探讨了促成核因子和抑成核因子在结石胆汁中的变化作用,为进一步阐明促/抑成核平衡在胆结石形成中的机制提供了一定基础。
Part one The synthetic study of the nucleation role of osteopontin in different model bile systems in vitro
Objective To investigate the nucleation role and the related mechanisms of osteopontin (OPN) in Small and Synthetic model bile systems in vitro. Methods The Small and Synthetic model bile systems have been prepared according the previously described methods, then the nucleation time assay and cholesterol crystal growth assay have been used to determine the nucleation role of the osteopontin in vitro. The effect of OPN on cholesterol-phosphalipids vesicles have been studied by the negative staining under the electron microscopy. Results OPN prolonged the nucleation time in Small and Synthetic model bile in vitro, this anti-nucleation role showed the dose dependent manner. While the calcium showed the pro-nucleation role in model bile, but this role was inhibited by OPN. Cholesterol crystal growth was inhibited by OPN in a dose dependent manner, but not affected by calcium. Furthermore, the formation, aggregation and fusion of vesicles were suppressed by OPN in model bile as demonstrated by transmission electron microscopy, and the vesicles were stabilized by OPN. Conclusions OPN played the anti-nucleation role in model bile systems and this role correlated with the calcium. These findings indicated OPN could inhibit the cholesterol gallstone formation by inhibiting cholesterol crystal nucleation, growth and stabilizing vesicles in model bile.
Part two The expression and nucleation role of OPN in human gallbladder bile
Objective To study the nucleation role of OPN in human gallbladder bile, and the concentrations of OPN and biliary lipids in lithogenic bile and control bile. Methods Nucleation role was determined in lithogenic bile and control bile in vitro. Effect of OPN on vesicles of bile was investigated via transmission electron microscopy. OPN and biliary lipids compositions in both gallbladder biles were determined via commercial kits. Results OPN prolonged nucleation time both in lithogenic gallbladder bile and control bile in vitro, this anti-nucleation role showed the dose dependent manner and played the effect at the physical concentration level. Calcium ions shortened nucleation time, but this effect was inhibited by OPN. Furthermore, the formation, aggregation and fusion of cholesterol-phospholipid vesicles were inhibited by OPN in human bile. The concentration of cholesterol, phospholipid, bile acids, and CSI were higher in lithogenic gallbladder bile than in normal gallbladder bile (P＜0.05); the contents of OPN and calcium, nevertheless, were found to be lower in lithogenic bile than those in normal controls. Conclusions OPN played the similar anti-nucleation role in human gallbladder bile as in model bile, which might inhibited the onset of the cholesterol crystal and the dynamic change of vesicles in human bile. These data might be a basis for further investigating the exact mechanism of OPN in the formation of cholesterol gallstone.
Part three Preliminary research of the expression menchanism of OPN and its receptors in cholesterol gallstone formation
Objective To investigate the expression of OPN and its receptors (integrin av, CD44) in cholesterol gallstone formation, and determine the OPN content in peripheral blood. Methods The immunostaining, mRNA and protein of OPN, integrin av and CD44 were analyzed in human lithogenic gallbladder tissue (case group I, with normal epithelia; case groupⅡ, with degenerated epithelia and fibrosis) and normal tissue. OPN content was detected by the ELISA kits. Results The immunostaining for OPN, integrin av and CD44 in human gallbladder tissues showed a higher reactivity in case groupⅠthan the control group, and in case group II, the immunostaining showed a lower reactivity. The mRNA and protein level of OPN, integrin av and CD44 in gallstone gallbladder tissue showed the similar results with the immunostaining assay in human gallbladder tissue. OPN content in blood showed the similar trend with that in gallbladder bile. Conclusions These data demonstrated that OPN, integrin av and CD44 were involved in gallstone formation as the dynamic change, the effect of OPN might be regulated by its receptors, OPN might be a potential blood marker molecule in gallstone formation.
Part Four Preliminary investigation of the dynamic changes of OPN in cholesterol gallstone formation
Objective To examine the dynamic expression of OPN in cholesterol gallstone formation, and the contents of OPN and other factors in gallbladder bile and blood. Methods Expression of OPN mRNA were detected by RT-PCR in gallbladder and hepatic tissues of cholesterol gallstone formation in guinea pig, contents of OPN and other factors in bile and blood were detected by ELISA kits. Results The lithogenic model have been established successfully in guinea pig. OPN mRNA expression in gallbladder and hepatic tissues were gradually increased and reached to the peak at the sixth week in lithogenic diet fed group, then decreased after six week. The contents of OPN in gallbladder bile and blood showed the similar results, but the peak value of OPN in blood was examined early than that in bile. The other anti-nucleation factor, apoprotein AI showed the similar results with OPN. However, pro-nucleation factors, mucin and AAP showed the increased value in bile and blood, which did not show the descended curve. Conclusions Function of gallbladder and liver might be involved in the anti-nucleation role of OPN, the differential changes of pro-nucleation and anti-nucleation factors in bile might played the important role in cholesterol gallstone formation.
In conclusion, the results suggested that OPN played an anti-nucleation role in cholesterol gallstone formation in vitro as the nucleation assays in model bile, and the role of OPN correlated with calcium and showed the dose dependent manner. Then it is found that the OPN showed the similar anti-nucleation role in human bile, and the role of OPN might be regulated by its receptors. Furthermore, the dynamic mechanism of OPN in the process of gallstone formation was determined via the guinea pig lithogenic model. We detected the dynamic role of the pro-nucleation and anti-nucleation factors in gallstone formation, and the possible mechanism of the nucleation equilibrium in cholesterol gallstone formation.
引文
[I]Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease [J]. Lancet,2006,368(9531):230-239.
[2]Wang DQH, Afdhal NH. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes [J]. Curr Gastroenterol Rep,2004,6(2): 140-150.
[3]Everhart JE, Khare M, Hill M, et al. Prevalence and ethnic differences in gallbladder disease in the United States [J]. Gastroenterology,1999,117(3): 632-639.
[4]Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States [J]. Gastroenterology,2002,122(5):1500-1511.
[5]Hou L, Shu XO, Gao YT, et al. Anthropometric measurements, physical activity, and the risk of symptomatic gallstone disease in Chinese women [J]. Ann Epidemiol,2009,19(5):344-350.
[6]祝学光.胆石病基础研究：关于成核、氨肽酶等方面的临床实验研究[J].中华肝胆外科杂志,2004,10(11)：726-728.
[7]Wang HH, Portincasa P, Wang DQH. Overexpression of estrogen receptor alpha (ER alpha) induces gallbladder hypomotility during cholesterol gallstone formation in mice [J]. Gastroenterology,2007,132(4):A2.
[8]Wittenburg H, Lammert F. Genetic predisposition to gallbladder stones [J]. Semin Liver Dis,2007,27(1):109-121.
[9]Lee DK, Tarr PI, Haigh WG, et al. Bacterial DNA in mixed cholesterol gallstones [J]. Am J Gastroenterol,1999,94(12):3502-3506.
[10]Somjen G, Gilat T. Contribution of vesicular and micellar carriers to cholesterol transport in human bile [J]. J Lipid Res,1985,26(6):699-704.
[11]Halpern Z, Dudley M, Kibe A, et al. Rapid vesicle formation and aggregation in abnormal human bile [J]. Gastroenterology,1986,90(4):875-885.
[12]Liao XM, Wiedmann TS. Formation of cholesterol crystals at a mucin coated substrate [J]. Pharm Res,2006,23(10):2413-2416.
[13]项建斌,蔡端,张延龄,等.胆汁成核效应蛋白的分离纯化与成核活性比较[J].中华肝胆外科杂志,2004,10(7)：453-456.
[14]Busch N, Matiuck N, Sahlin S, et al. Inhibition and promotion of cholesterol crystallization by protein factors from normal human gallbladder bile [J]. J Lipid Res,1991,32(4):695-702.
[15]Lee SM, Lamont JT, Carey MC. Role of gallbladder mucus hypersecretion in the evolution of cholesterol fallstones [J]. J Clin Invest,1981,67(6):1712-1723.
[16]Dayan YB, Vilkin A, Niv Y. Gallbladder mucin plays a role in gallstone formation [J]. Eur J Intern Med,2004,15(7):411-414.
[17]Miquel JF, Nunez L, Amigo L, et al. Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile [J]. Gastroenterology,1998,114(5):1016-1023.
[18]陈雨强,张延龄,蔡端,等.胆汁刀豆凝集素A结合蛋白在胆固醇结石早期形成阶段的作用[J].中华实验外科杂志,1996,13(4)：199-200.
[19]励峰,蔡端,莫汉庆,等.ELISA法检测200kDa糖蛋白[J].中华消化杂志,1997,17(6)：333-335.
[20]Holzbach RT, Kibe A, Thiel E, et al. Biliary proteins:unique inhibitors of cholesterol crystal nucleation in human gallbladder bile [J]. J Clin Invest,1984, 73(1):35-45.
[21]Kibe A, Holzbach RT. Inhibition of cholesterol crystal formation by apolipo-proteins in supersaturated model bile [J]. Science,1984,255(4661):514-516.
[22]Secknus R, Darby GH, Chernosky A, et al. Apolipoprotein A-I in bile inhibitors cholesterol crystallization and modifies transcellular lipid transfer through cultured human gallbladder epithelial cells [J]. J Gastroenterol Hepatol,1999, 14(5):446-456.
[23]Mazzali M, Kipari T, Ophascharoensuk V, et al. Osteopontin-a molecule for all seasons [J]. QJM,2002,95(1):3-13.
[24]Gericke A, Qin C, Spevak L, et al. Importance of phosphorylation for osteopontin regulation of biomineralization [J]. Calcif Tissue Int,2005,77(1):45-54.
[25]Arafat HA, Wein AJ, Chacko S. Osteopontin gene expression and immunolocalization in the rabbit urinary tract [J]. J Urol,2002,167(2):746-752.
[26]Brown LF, Berse B, Van De Water L, et al. Expression and distribution of osteopontin in human tissues:widespread association with luminal epithelial surfaces [J]. Mol Biol Cell,1992,3(10):1169-1180.
[27]Butler WT. The nature and significance of osteopontin [J]. Connect Tissue Res, 1989,23(2):123-136.
[28]Denhardt DT, Guo X. Osteopontin:a protein with diverse functions [J].FASEB J, 1993,7(15):1475-1482.
[29]Xie YS, Sakatsume M, Nishi S, et al. Expression, roles, receptors, and regulation of osteopontin in the kidney [J]. Kidney Int,2001,60(5):1645-1657.
[30]Jeffrey AW, Richard JJ, Marrilda M, et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules [J]. J Am Soc Nephrol,2003,14(1):139-147.
[31]Watts RWE. Idiopathic urinary stone disease:possible polygenic aetiological factors [J]. QJM,2005,98(4):241-246.
[32]Hoyer JR. Uropontin in urinary calcium stone formation [J]. Miner Electrolyte Metab,1994,20(6):385-392.
[33]Hoyer JR, Asplin JR, Otvos L. Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals [J]. Kidney Int.2001,60(1):77-82.
[34]Lieske JC, Leonard R, Toback F. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions [J]. Am J Physiol, 1995,268(4):F604-612.
[35]Bing G, Takahiro Y, Atsushi O, et al. A polymorphism of the osteopontin gene is related to urinary calcium stones [J]. J Urology,2005,174(4 pt 1):1472-1476.
[36]Moore EW. Biliary calcium and gallstone [J]. Hepatology,1990,12(3 pt 2): S206-S214.
[37]Nakai K, Tasuma S, Ochi H, et al. Does bilirubin play a role in the pathogenesis of both cholesterol and pigment gallstone formation? Direct and indirect influence of bilirubin on bile lithogenecity [J]. Biochim Biophys Acta,2001, 1534(2-3):78-84.
[38]Sahai A, Malladi P, Melin-Aldana H, et al. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model [J]. Am J Physiol Gastrointest Liver Physiol,2004,287(1): G264-G273.
[39]Whitington PF, Malladi P, Melin-Aldana H, et al. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia [J]. Pediatr Res.2005,57(6):837-44.
[1]Hou L, Shu XO, Gao YT, et al. Anthropometric measurements, physical activity, and the risk of symptomatic gallstone disease in Chinese women [J]. Ann Epidemiol,2009,19(5):344-350.
[2]Cetta F, Lombardo F, Giubbolini M, et al. Classification of gallstones and epidemiologic studies [J]. DigDis Sci,1995,40(10):2189-2191.
[3]Cetta F, Lombardo F, Giubbolini M, et al. Quantity and location of stone compounds, not the mere presence in small amounts within the stone fabric, are important factors for the correct classification of the gallstones and a better knowledge of their pathogenesis [J]. Hepatology,1995,23(5):1285-1287.
[4]赵纪春,舒哗,程南生,等.胆囊结石中胆固醇代谢变化的实验研究[J].中国普通外科杂志,2000,9(2)：124-128.
[5]Moore EW. Biliary calcium and gallstones formation [J]. Hepatology,1990,12(3 pt2):S206-S214.
[6]Levy PF, Smith BF, LaMont JT, Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile [J]. Gastroenterology,1984,87 (2):270-275.
[7]Xiang JB, Cai D, Ma BJ, et al. Purification and characterization of 33.5 kDa vesicular protein in human bile [J]. World J Gastroenterol,2003,9(11): 2539-2543.
[8]Miquel JF, van der Putten J, Pimentel F, et al. Increased activity in the biliary Con A-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients [J]. Hepatology,2001,33(2):328-332.
[9]Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man [J]. J Clin Invset,1968,47(5):1043-1052.
[10]Wang DQH, Carey MC. Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles:identical pathways to corresponding model biles with three predominating sequences [J]. J Lipid Res, 1996,37(12):2539-2549.
[11]朱雷明,蔡端,张延龄。模拟胆汁体系中游离胆红素的热力学研究[J].外科理论与实践,1999,4(1)：13-17.
[12]Holan KR, Holzbach RT, Hermann HE, et al. Nucleation time:a key factor in the pathogenesis of cholesterol gallstone disease [J]. Gastroenterology,1979,77(4 pt 1):611-617.
[13]Yamashita Y, Tazuma S, Kajiyama G. Method for quantitative assessment of transformation of non-micellar cholesterol carriers in model bile systems [J]. J Gastroenterol Hepatol,1996,11(9):864-869.
[14]Busch N, Tokumo H, Holzbach RT. A sensitive method for determination of cholesterol growth using model solutions of supersaturated bile [J]. J Lipid Res, 1990,31(10):1903-1909.
[15]Denhardt DT, Guo X. Osteopontin:A protein with diverse functions [J]. FASEB J,1993,7(15):1475-1482.
[16]Qu H, Brown LF, Senger DR, et al. Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells [J]. J Histochem Cytochem, 1994,42(3):351-361.
[17]Yasui T, Fujita K, Hayashi Y, et al. Quantificantion of osteopontin in the urine of healthy and stone-forming men [J]. Urol Res,1999,27(4):225-230.
[18]Kibe A, Dudley MA, Halpern DZ, et al. Factors influencing cholesterol monohydrate crystal nucleation time in model systems of supersaturated bile [J]. J Lipid Res,1985,26(9):1102-1111.
[19]孙劲文,蔡端,马保金,等.综合模拟胆汁体系中未结合胆红素与胆固醇的溶解方式[J].肝胆胰外科杂志,2004,16(1)：23-25.
[20]Busch N, Matiuck N, Sahlin S, et al. Inhibition and promotion of cholesterol crystallization by protein fraction from normal human gallbladder bile [J]. J Lipid Res,1991,32(4):695-702.
[21]Carey MC, Small DM. The physical chemistry of cholesterol solubility in bile. Relation to gallstone formation and dissolution in man [J]. J Clin Invest,1978, 61(4):998-1026.
[22]Holzbach RT, Marsh M, Kwasnick RF, et al. Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man [J]. J Clin Invest, 1973,52(6):1467-1479.
[23]Mazer NA, Carey MC. Quasi-elastic lightscattering studies of aqueous biliary lipid systems.Cholesterol solubilization and precipitation in model bile solutions [J]. Biochemistry,1983,22(2):426-442.
[24]Somjen GJ, Gilat T. A non-micellar mode of cholesterol transport in human bile [J]. FEBS Lett,1983,156(2):265-268.
[25]Somjen GJ, Gilat T. Contribution of vesicular and meciller carriers to cholestrerol transport in human bile [J]. J Lipid Res,1985,26(6):699-704.
[26]Halpern Z, Dudley MA, Lynn MP, et al. Vesicle aggregation in model systems of supersaturated bile:relation to crystal nucleation and lipid composition of the vesicle phase [J]. J Lipid Res,1986,27(3):295-306.
[27]Moser AJ, Abedin MZ, Roslyn JJ. Increased biliary protein precedes gallstone formation [J]. Dig Dis Sci,1994,39(6):1313-1320.
[28]Oldberg A, Franzen A, Heinegard D. Cloning and se-quence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp Cell-binding sequence [J]. Proc Natl Acad Sci USA,1986,83(23):8819-8823.
[29]O'Young J, Chirico S, Al Tarhuni N, et al. Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals [J]. Cells Tissues Organs,2009,189(1-4):51-55.
[30]Kleinman JK, Wessona JA, Hughesb J. Osteopontin and Calcium Stone formation [J]. Nephron Physiol,2004,98(2):43-47.
[31]Nakai A, Imnao M, Takeyama Y, et al. An immunohistochemical study of osteopontin in hepatolithiasis [J]. J Hepatobiliary Pancreat Surg,2009,15(6): 615-621.
[32]Dixit M, Choudhuri G, Saxena R, et al. Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease [J]. Can J Gastroenterol,2007, 21(9):569-575.
[33]Ostrow JD. APF/CBP, an anionic polypeptide in bile and gallstones that may regulate calcium salt and cholesterol precipitation from bile [J]. Hepatology, 1992,16(6):1493-1496.
[34]Liaw L, Skinner MP, Raines EW, et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins:Role of αvβ3 in smooth muscle migration to osteopontin in vitro [J]. J Clin Invest,1995,95(2): 713-724.
[35]Konikoff FK, de la Porte PL, Laufer H, et al. Calcium and the anionic polypeptide fraction (APF) have opposing effects on cholesterol crystallization in model bile [J]. J Hepatol,1997,27(4):707-715.
[36]Lafont H, Domingo N, Groen A, et al. APF/CBP, the Small, Amphipathic, Anionic Protein(s) in Bile and Gallstones, Consists of Lipid-Binding and Calcium-Binding Forms [J]. Hepatology,1997,25(5):1054-1063.
[1]Holzbach RT, Kibe A, Thiel E, et al. Biliary proteins, unique inhibitors of cholesterol crystal nucleation in human gallbladder bile [J]. J Clin Invest,1984, 73(1):35-45.
[2]Sewell RB, Mao SJ, Kawamoto T, et al. Apolipoproteins of high, low, and very low density lipoproteins in human bile [J]. J Lipid Res,1983,24(4):391-401.
[3]Kibe A, Holzbach RT, LaRusso NF, et al. Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile [J]. Science,1984, 225(4661):514-516.
[4]Teramen K, Tazuma S, Ohya T, et al. Comparative effects on biliary concanavalin A-bound glycoproteins and calcium ionson cholesterol crystal nucleation and growth in model bile [J]. J gastroenterol,1995,30(4):500-507.
[5]傅培彬,张圣道,郑魁元,等.168例胆石化学成份分析[J].中华消化杂志,1983,3(3)：170-172.
[6]Strasberg SM, Harvey PRC, Hofmann AF. Bile sampling, processing and analysis in clinical-studies [J]. Hepatology,1990,12(3):S176-S182.
[7]Holan KR, Holzbach RT, Hermann RE, et al. Nucleation time:a key factor in the pathogenesis of cholesterol gallstone disease[J]. Gastroenterology,1979,77(4 pt 1):611-617.
[8]Carey MC. Critical tables for calculating the cholesterol saturation of native bile [J]. J Lipid Res,1978,19(8):945-955.
[9]Kibe A, Dudley MA, Halpern Z, et al. Factors affecting cholesterol monohydrate crystal nucleation time in model systems of supersaturated bile [J]. J Lipid Res, 1985,26(9):1102-1111.
[10]常连胜,冯陶,郭应禄,等.结石病人尿骨桥蛋白测定的临床意义[J].中华泌尿外科杂志,2000,21(12)：907-909.
[11]Kleinman JK, Wessona JA, Hughesb J. Osteopontin and Calcium Stone formation [J]. Nephron Physiol,2004,98(2):43-47.
[12]Moore EW. Biliary calcium and gallstone formation [J]. Hepatology,1990,12(3 pt2):S206-S214.
[13]Singh K, Deonarine D, Shanmugam V, et al. Calcium-binding properties of osteopontin derived from non-osteogenic sources [J]. J Biochem,1993,114(5): 702-727.
[14]Lafont H, Domingo N, Groen A, et al. APF/CBP, the Small, Amphipathic, Anionic Protein(s) in Bile and Gallstones, Consists of Lipid-Binding and Calcium-Binding Forms [J]. Hepatology,1997,25(5):1054-1063.
[15]Kaufman HS, Magnuson TH, Pitt HA, et al. The distribution of calcium salt precipitates in the core, periphery and shell of cholesterol, black pigment and brown pigment gallstones [J]. Hepatology,1994,19(5):1124-32.
[16]Liao XM, Wiedmann TS. Formation of cholesterol crystals at a mucin coated substrate [J]. Pharmaceutical Research,2006,23(10):2413-2416.
[17]van Erpecum KJ. Biliary lipids, water and cholesterol gallstones [J]. Biology of the Cell,2005,97(11):815-822.
[18]Halpern Z, Dudley M, Kibe A, et al. Rapid vesicle formation and aggregation in abnormal human bile [J]. Gastroenterology,1986,90(4):875-885.
[19]Wang DQH, Carey MC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile:influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing system [J]. J Lipid Res,1996,37(3):606-630.
[20]O'leary DP. Biliary cholesterol transport and the nucleation defect in cholesterol gallstone formation [J]. J Hepatol,1995,22(2):239-246.
[21]Abei M, Schwarzendrube J, Nuutinen H, et al. Cholesterol crystallization-promoters in human bile-comparative potencies of immunoglobulins, Alpha(1)-acid glycoprotein, phospholipase-C, and aminopeptidase-N [J]. J Lipid Res,1993, 34(7):1141-1148.
[22]Abei M, Nuutinen H, Kawczak P, et al. Identification of human biliary Alpha (1)-acid glycoprotein as a cholesterol crystallization promoter [J]. Gastroenterology,1994,106(1):231-238.
[23]Jungst D, Lang T, Ritter CV, et al. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones [J].1992, Hepatology, 15(5):804-808.
[24]Gollish SH, Burnstein MJ, Ilson RG, et al. Nucleation of cholesterol monohydrate crystals from hepatic and gallbladder bile of patients with cholesterolgallstones [J]. Gut,1983,24(9):836-844.
[25]Knyrim K, Vakil N. Bile composition, microspheroliths, antinucleating activity, and gallstone calcification [J]. Gastroenterology,1992,103(2):552-559.
[26]O'Young J, Chirico S, A1 Tarhuni N, et al. Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals [J]. Cells Tissues Organs,2009,189(1-4):51-55.
[1]Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease [J]. Lancet,2006,368(9531):230-239.
[2]Tuck AB, Hota C, Wilson SM, et al. Osteopontin induced migration of human mammary epit helial cells involves activation of EGF receptor and multiple signal t ransduction pat hways [J]. Oncogene,2003,22 (8):1198-1205.
[3]Marroquin CE, Downey L, Guo H, et al. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells [J]. Immunol Lett,2004,95(1):109-112.
[4]Ellen MG. Osteopontin:a bridge between bone and immune system [J]. J Clin Invest,2003,112 (2):147-149.
[5]傅培彬,张圣道,郑魁元,等.168例胆石化学成份分析[J].中华消化杂志,1983,3(3)： 170-172.
[6]Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent [J]. J Biol Chem,1951,193(1):265-275.
[7]Denhardt DT, Guo X. Osteopontin:A protein with diverse functions [J]. FASEB J,1993,7(15):1475-1482.
[8]Brown LF, Berse B, Van de Water L, et al. Expression and distribution of osteopontin in human tissues:widespread association with luminal epithelial surfaces [J]. Mol Biol Cell,1992,3(10):1169-1180.
[9]Qu H, Brown LF, Senger DR, et al. Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells [J]. J Histochem Cytochem, 1994,42(3):351-361.
[10]Liaw L, Skinner MP, Raines EW, et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins:Role of avB3 in smooth muscle migration to osteopontin in vitro [J]. J Clin Invest,1995,95(2): 713-724.
[11]Weber GF, Ashkar S, Glimcher MJ, et al. Receptor-ligand interaction between CD44 and osteopontin (ETA-1) [J]. Science,1996,271(5248):509-512.
[12]Chakraborty G, Jain S, Behera R, et al. The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis [J]. Curr Mol Med,2006,6 (8):819-830.
[13]Chellaiah MA, Biswas RS, Rittling SR, et al. Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts [J]. J Biol Chem,2003,278 (31):29086-29097.
[14]Denhardt D. Osteopontin expression correlates wit h melanoma invasion [J]. J Invest Dermatol,2005,124(5):16-18.
[15]Nakai A, Imano M, Takeyama Y, et al. An immunohistochemical study of osteopontin in hepatolithiasis [J]. J Hepatobiliary Pancreat Surg,2008,15(6): 615-621.
[16]Ichikawa H, Imano M, Takeyama Y, et al. Involvement of osteopontin as a core protein in cholesterol gallstone formation [J]. J Hepatobiliary Pancreat Surg, 2009,16(2):197-203.
[17]Farach-Carson MC, Xu Y. Microarray detection of gene expression changes induced by 1,25(OH)(2)D(3) and a Ca(2+) influx-activating analog in osteoblastic ROS 17/2.8 cells [J]. Steroids,2002,67(6):467-470.
[18]Dibya D, Arora N, Smith EA. Noninvasive measurements of integrin microclustering under altered membrane cholesterol levels [J]. Biophys J,2010, 99(3):853-861.
[19]Pankov R, Markovska T, Hazarosova R, et al. Cholesterol distribution in plasma membranes of betal integrin-expressing and beta1 integrin-deficient fibroblasts [J]. Arch Biochem Biophys,2005,442(2):160-168.
[20]Dray-Charier N, Paul A, Combettes L, et al. Regulation of Mucin Secretion in Human Gallbladder Epithelial Cells:Predominant Role of Calcium and Protein Kinase C [J]. Gastroenterology,1997,112(3):978-990.
[21]Shoda J, He BF, Tanaka N, et al. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit [J]. Hepatology,1995,21(5):1291-1302.
[22]Xiao ZL, Chen Q, Amaral J, et al. Defect of receptor-G protein coupling in human gallbladder with cholesterol stones [J]. Am J Physiol Gastrointest Liver Physiol,2000,278(2):G251-G258.
[23]Xiao ZL, Amaral J, Biancani P, et al. Impaired cytoprotective function of muscle in human gallbladders with cholesterol stones [J]. Am J Physiol Gastrointest Liver Physiol,2005,288(3):G525-G532.
[24]van Erpecum KJ, Venneman NG, Portincasa P, et al. Review article:agents affecting gallbladder motility-role in treatment and prevention of gallstones [J]. Aliment Pharmacol Ther,2000,14(S2):66-70.
[25]Moschetta A, Stolk MF, Rehfeld JF, et al. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR [J]. Aliment Pharmacol Ther,2001,15(2):181-185.
[26]Sitzmann JV, Pitt HA, Steinborn PA, et al. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans [J]. Surg Gynecol Obstet,1990, 170(1):25-31.
[27]Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones:a parsimonious hypothesis [J]. Eur J Clin Invest,1996,26(5):343-352.
[28]焦宛,张延龄,钟慈声.胆囊结石患者胆囊上皮细胞超微结构的图像学分析[J].上海医学,1994,17(7)：373-375.
[29]钱昌林,杨林,陈进宏,等.人胆囊组织蛋白质表达谱的建立[J].外科理论与实践,2010,15(1)：38-42.
[30]Kariuki SN, Moore JG, Kirou KA, et al. Age-and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus [J]. Genes Immun,2009,10(5):487-494.
[31]Schack L, Lange A, Kelsen J, et al. Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas [J]. J Dairy Sci, 2009,92(11):5378-5385.
[32]Tsuji H, Tohru U, Hirotsugu U, et al. Urinary concentration of osteopontin and association with urinary supersaturation and crystal formation [J]. Int J Urol, 2007,14(7):630-634.
[33]Nagatomo T, Ohga S, Takada H, et al. Microarray analysis of human milk cells: persistent high expression of osteopontin during the lactation period [J]. Clin Exp Immunol,2004,138(1):47-53.
[1]Hay DW, Carey MC. Pathophysiology and pathogenesis of cholesterol gallstone formation [J]. Semin Liver Dis,1990,10(3):159-170.
[2]Hofmann AF. Pathogenesis of cholesterol gallstones [J]. J Clin Gastroenterol, 1988,10(S2):S1-S11.
[3]Marschall HU, Einarsson C. Gallstone disease [J]. Journal of Internal Medicine, 2007,261(6):529-542.
[4]Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States [J]. Gastroenterology,2002,122(5):1500-1511.
[5]Portincasa P, Moschetta A, Mazzone A, et al. Water handling and aquaporins in bile formation:recent advances and research trends [J]. J Hepatol,2003,39(5): 864-874.
[6]Katsika D, Grjibovski A, Einarsson C, et al. Genetic and environmental influences on symptomatic gallstone disease:a Swedish study of 43,141 twin pairs [J]. Hepatology,2005,41(5):1138-1143.
[7]Brown LF, Berse B, Van de Water L, et al. Expression and distribution of osteopontin in human tissues:widespread association with luminal epithelial surfaces [J]. Mol Biol Cell,1992,3(10):1169-1180.
[8]Qu H, Brown LF, Senger DR, et al. Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells [J]. J Histochem Cytochem, 1994,42(3):351-361.
[9]Gotoh M, Sakamoto M, Kanetaka K, et al. Overexpression of osteopontin in hepatocellular carcinoma [J]. Pathol Int,2002,52(1):19-24.
[10]Reihner E, Stahlberg D. Lithogenic diet and gallstone formation in mice: integrated response of activities of regulatory enzymes in hepatic cholesterol metabolism [J]. Br J Nutr,1996,76(5):765-772.
[11]Gosiewska A, Wilson S, Kwon D, et al. Evidence for an in vivo role of insulin-like growth factor-binding protein-1 and -2 as inhibitors of collagen gene expression in vitamin C-deficient and fasted guinea pigs [J]. Endocrinology, 1994,134(3):1329-1339.
[12]Shiesh SC, Chen CY, Lin XZ, et al. Melatonin Prevents Pigment Gallstone Formation Induced by Bile Duct Ligation in Guinea Pigs [J]. Hepatology,2000, 32(3):455-460.
[13]Mahmoodian F, Gosiewska A, Peterkofsky B. Regulation and Properties of Bone Alkaline Phosphatase during Vitamin C Deficiency in Guinea Pigs [J]. Arch Biochem Biophys,1996,336(1):86-96.
[14]周文江,杨幼明,方玉梅,等.豚鼠胆囊胆固醇结石模型的建立[J].中国实验动物学杂志,1999,9(4)：198-201.
[15]韩天权,张圣道.胆石病流行病学研究的现状和发展[J].胃肠病学,2003,8(3)：166-168.
[16]Mendez-Sanchez N, Zamora-Valdes D, Chavez-Tapia NC, et al. Role of diet in cholesterol gallstone formation [J]. Clin Chim Acta,2007,376 (1-2):1-8.
[17]Pacchioni M, Nicoletti C, Caminiti M, et al. Association of obesity and type II diabetes mellitus as a risk factor for gallstones [J]. Dig Dis Sci,2000,45(10): 2002-2006.
[18]Dam H. Determinants of cholesterol cholelithiasis in man and animals [J]. Am J Med,1971,51(5):596-613.
[19]Holzbach RT. Animal models of cholesterol gallstone disease [J]. Hepatology, 1984,4(5):S191-S198.
[20]Lofland HB. Animal models of human disease:cholelithiasis [J]. Am J Pathol, 1975,79(3):619-622.
[21]Gurll N, DenBesten L. Animal models of human cholesterol gallstone disease:a review [J]. Lab Anim Sci,1978,28(4):428-432.
[22]别平,黄志强,韩本立,等.高胆固醇饲料对豚鼠胆囊组织分泌糖蛋白的影响.第三军医大学学报,1999,21(1)：48-50.
[23]李均乐,田立新.绞股蓝预防豚鼠胆囊胆固醇结石形成[J].中华肝胆外科杂志,2002,8(10)：609-610.
[24]Jenkins SA. Hypovitaminosis C and cholelithiasis in guinea pigs [J]. Biochem Biophys Res Commun,1977,77(3):1030-1035.
[25]Amigo L, Quinones V, Mardones P, et al. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet [J]. Gastroenterology,2000,118 (4):772-779.
[26]Brotschi EA, Pattavino J, Williams LF. Intrinsic nerves affect gallbladder contraction in the guinea pig [J]. Gastroenterology,1990,99(3):826-830.
[27]肖勇,余保平,吴志轩,等.胆囊收缩素对胆固醇结石豚鼠离体胆囊肌条的影响[J].世界华人消化杂志,2008,16(20)：2280-2284.
[28]Marin JJ, Serrano MA, Mirmy El, et al. Bile acid transport by basal membrance vesicles of human term placental trophoblast [J]. Gastroenterology,1990,99(5): 1431-1433.
[29]Gerloff T, Stieger B, Hagenbuch B, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver [J]. J Biol Chem,1998, 273(16):10046-10050.
[30]Acalovschi M. Cholesterol gallstones:from epidemiology to prevention [J]. Postgrad Med J,2001,77(906):221-229.
[31]Lammert F, Sauerbruch T. Mechanisms of disease:the genetic epidemiology of gallbladder stones [J]. Nat Clin Pract Gastroenterol Hepatol,2005,2(9): 423-433.
[32]姜皓,施维锦.熊胆预防豚鼠胆囊胆固醇结石的实验研究[J].上海医学,2000,23(7)：417-419.
[33]Dayan YB, Vilkin A, Niv Y. Gallbladder mucin plays a role in gallstone formation [J]. Eur J Intern Med,2004,15(7):411-414.
[34]Abei M, Nuutinen H, Kawczak P, et al. Identification of human biliary Alpha(1)-acid glycoprotein as a cholesterol crystallization promoter [J]. Gastroenterology,1994,106(1):231-238
[35]Ohya T, Schwarzendrube J, Busch N, et al. Isolation of a human biliary glycoprotein inhibitor of cholesterol crystallization [J]. Gastroenterology,1993, 104(2):527-538.
[36]Busch N, Holzbach RT. Crystal growth-inhibiting proteins in bile [J]. Hepatology, 1990,12(3):S195-S198.
[1]韩天权,张圣道.胆石病流行病学研究的现状和发展[J].胃肠病学,2003,8(3)：166-168.
[2]Misciagna G, Centonze S, Leoci C, et al. Diet, physical activity, and gallstones-a population-based, case-control study in southern Italy [J]. Am J Clin Nut,1999, 69(1):120-126.
[3]Hou L, Shu XO, Gao YT, et al. Anthropometric measurements, physical activity, and the risk of symptomatic gallstone disease in Chinese women [J]. Ann Epidemiol,2009,19(5):344-350
[4]Groen AK, Noordam C, Drapers JA, et al. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile:role in the pathogenesis of gallstone disease [J]. Hepatology,1990, 11(4):525-533.
[5]Zhou H, Chen B, Li RX, et al. Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach [J]. Rapid Communications in Mass Spectrometry,2005,19(23):3569-3578
[6]Miquel JF, Putten J, Pimentel F, et al. Increased activity in the biliary ConA-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients [J]. Hepatology,2001,33(2):328-332.
[7]Lammert F, Sauerbruch T. Mechanisms of disease:the genetic epidemiology of gallbladder stones [J]. Nat Clin Pract Gastroenterol Hepatol,2005,2(9): 423-433.
[8]Paumgartner G, Sauerbruch T. Gallstones:pathogenesis [J]. Lancet,1991, 338(8775):1117-1121.
[9]Small DM. Role of ABC transporters in secretion of cholesterol from liver into bile [J]. Proc Natl Acad Sci USA,2003,100(1):4-6.
[10]Robins SJ, Fasulo JM, Lessard PD, et al, Hepatic cholesterol synthesis and the secretion of newly synthesized cholesterol in bile [J]. Biochem J,1993,289(pt1): 41-44.
[11]Groen AK, Bloks VW, Bandsma RH, et al. Hepatobiliary cholesterol transport is not impaired in Abcal-null mice lacking HDL [J]. J Clin Invest,2001,108(6): 843-850.
[12]Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver Ⅹ receptors alpha and beta [J]. J Biol Chem,2002,277(21):18793-18800.
[13]Moschetta A, Bookout AL, Mangelsdorf DJ. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model [J]. Nat Med,2004,10(12): 1352-1358.
[14]Carey MC, Small DM. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man [J]. J Clin Invest, 1978,61(4):998-1026.
[15]Holzbach RT, Marsh M, Olsezwski M, et al. Cholesterol solubility in bile: evidence that supersaturated bile is frequent in healthy man [J]. J Clin Invest, 1973,52(6):1467-1479.
[16]Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man [J]. J Clin Invest,1968,47(5):1043-1052.
[17]Gustafsson U, Sahlin S, Einarsson C. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstonefree subjects:deoxycholic acid does not contribute to formation of cholesterol gallstones [J]. Eur J Clin Invest, 2000,30(12):1099-1106.
[18]Miquel JF, Nunez L, Amigo L, et al. Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile [J]. Gastroenterology,1998,114(5):1016-1023.
[19]Somjen GJ, Gilat T. A non-micellar mode of cholesterol transport in human bile [J]. FEBS Lett,1983,156(2):265-268.
[20]Somjen GJ, Gilat T. Contribution of vesicular and meciller carriers to cholestrerol transport in human bile [J]. J Lipid Res,1985,26(6):699-704.
[21]Halpern Z, Dudley MA, Lynn MP, et al. Vesicle aggregation in model systems of supersaturated bile:relation to crystal nucleation and lipid composition of the vesicle phase [J]. J Lipid Res,1986,27(3):295-306
[22]Halpern Z, Dudley MA, Kibe A, et al. Rapid vesicle formation and aggregation in abnormal human biles. A time-lapse video-enhanced contrast microscopy study [J]. Gastroenterology,1986,90(4):875-885.
[23]Cohen DE, Carey MC. Physical chemistry of biliary lipids during bile formation [J]. Hepatology,1990,12(3 pt 2):S143-S148.
[24]Eckhardt ER, Van de Heijning BJM, Van Erpecum KJ, et al. Quantitation of cholesterol carrying particles in human gallbladder bile [J]. J Lipid Res,1998, 39(3):594-603.
[25]Harvey PR, Somjen G, Gilat T, et al. Vesicular cholesterol in bile. Relationship to protein concentration and nucleation time [J]. Biochim Biophys Acta,1988, 958(1):10-8.
[26]Holan KR, Holzbach RT, Hermann HE, et al. Nucleation time:a key factor in the pathogenesis of cholesterol gallstone disease [J]. Gastroenterology,1979,77(4 pt 1):611-617.
[27]Holzbach RT. Recent progress in understanding cholesterol crystal nucleation as a precursor to human gallstone formation [J]. Hepatology,1986,6(6):1403-1406.
[28]Afdhal NH, Niu N, Gantz D, et al. Bovine gallbladder mucin accelerates cholesterol monohydrate crystal growth in model bile [J]. Gastroenterology, 1993,104(5):1515-1523.
[29]Busch N, Tokumo H, Holzbach RT. A sensitive method for determination of cholesterol growth using model solutions of supersaturated bile [J]. J Lipid Res, 1990,31(10):1903-1909.
[30]Afdhal NH, Niu N, Nunes DP, et al. Mucin-vesicle interactions in model bile: evidence for vesicle aggregation and fusion before cholesterol crystal formation [J]. Hepatology,1995,22(3):856-865.
[31]Smith BE. Human gallbladder mucin binds biliary lipids and promotes cholesterol nucleation in model bile [J]. J Lipid Res,1987,28(9):1088-1097.
[32]Gallinger S, Taylor RD, Harvey PR, et al. Effect of mucous glycoprotein on nucleation time of human bile [J]. Gastroenterology,1985,89(3):648-658.
[33]Nuutinen H, Corradini SG, Jungst D, et al. Correalation between biliary α1-acid glycoprotein concentration and cholesterol crystal nucleation time in gallstone disease [J]. Dig Dis Sci,1995,40(6):1174-1178.
[34]Groen AK, Ottenhoff R, Jansen PL, et al. Effect of cholesterol nucleation promoting activity on cholesterol solubilization in model bile [J]. J Lipid Res, 1989,30(1):51-58.
[35]Upadhya GA, Harvey PR, Strasberg SM. Effect of human biliary immunoglo-bulins on the nucleation of cholesterol [J]. J Biol Chem,1993,268(7):5193-5200.
[36]Nakeeb SA, Barnes KD, Lillemoe HA, et al. Immunoglobulins in gallstone pathogenesis:A systemic or a local phenomenon [J]? Gastroenterology,1995, 108(4):A1092.
[37]Abei M, Schwarzendrube J, Nuutinen H, et al. Cholesterol crystallization-promoters in human bile:comparative potencies of immunoglobulins, alpha 1-acid glycoprotein, phospholipase C, and aminopeptidase N1 [J]. J Lipid Res, 1993,34 (7):1141-1148.
[38]Harvey PR, Upadhya GA, Strasberg SM. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones [J]. J Biol Chem,1991,266(21):13996-14003.
[39]Pattinson NR. Identification of a phosphatidylcholine active phospolipase C in human gallbladder bile [J]. Biochem Biophys Res Commun,1988,150(2): 890-896.
[40]Pattinson NR, Willis KE. Effect of phospholipase C on cholesterol solubilization in model bile. A concanavalin Abinding nucleation-promoting factor from human gallbladder bile [J]. Gastroenterology,1991,101(5):1339-1344.
[41]Halpern Z, Goldman G, Peled Y, et al. Free fatty acids have nucleating effects in model biles [J]. Liver,1992,12(3):107-111.
[42]Sunami Y, Tazuma S, Chayama K, et al. Is a role of phospholipase A2 in cholesterol gallstone formation phospholipid species-dependent [J]? Biochim Biophys Acta,2001,1532 (1-2):51-59.
[43]Nakayama F, Johnston CG. Fractionation of bile lipids with silicic acid and column chromatography [J]. J Lab Clin Med,1962,59(12):364-370.
[44]Halpern Z, Moshkowitz M, Laufer H, et al. Effect of phospholipids and their molecular species on cholesterol solubility and nucleation in human and model biles [J]. Gut,1993,34 (1):110-115.
[45]Offner GD, Gong D, Afdhal NH. Identification of a 130-kilodalton human biliary Concanavalin-A binding protein as aminopeptidase N [J]. Gastroenterology, 1994,106(3):755-762.
[46]Xiang JB, Cai D, Ma BJ,et al. Purification and characterization of 33.5 kDa vesicular protein in human bile [J]. World J Gastroenterol,2003,9 (11):2539-2543.
[47]张殿彩,项建斌,蔡端,王丽影,查锡良.胆汁泡相与微胶粒相的蛋白质表达谱对比观察[J].中华医学杂志,2008,88(46)：3298-3301.
[48]Schuber F, Hong K, Duzgunes N, et al. Polyamines as modulators of membrane fusion:aggregation and fusion of liposomes [J]. Biochemistry,1983,22 (26): 6134-6140.
[49]Konikoff F, Goldman G, Halpern Z, et al. Polyamines--potential nucleating factors in bile [J]. Liver,1990,10 (3):173-176.
[50]Moore E. The Role of Calcium in the Pathogenesis of Gallstones:Ca2+ Electrode Studies of Model Bile Salt Solutions and Other Biologic Systems With an Hypothesis on Structural Requirements for Ca++ Binding to Proteins and Bile Acids [J]. Hepatology,1984,4(5):S228-S243.
[51]Strichartz SD, Abedin MZ, Abdou MS, et al. Increased biliary calcium in cholesterol gallstone formation [J]. Am J Surg,1988,155 (1):131-137.
[52]de la Porte PL, Domingo N, van Wijland M, et al. Distinct immuno-localization of mucin and other biliary proteins in human cholesterol gallstones [J]. J Hepatol, 1996,25(3):339-348.
[53]Lafont H, Domingo N, Groen A, et al. APF/CBP, the Small, Amphipathic, Anionic Protein(s) in Bile and Gallstones, Consists of Lipid-Binding and Calcium-Binding Forms[J]. Hepatology,1997,25(5):1054-1063.
[54]Moore EW. Biliary Calcium and Gallstone Formation [J]. Hepatolgy,1990,12(3): S206-S213.
[55]Ohya T, Schwarzendrube J, Busch N, et al. Isolation of a human biliary glycoprotein inhibitor of cholesterol crystallization [J]. Gastroenterology,1993, 104(2):527-538.
[56]Busch N, Lammert F, Marschall HU, et al. A new subgroup of lectin-bound biliary proteins binds to cholesterol crystals, modifies crystal morphology, and inhibits cholesterol crystallization [J]. J Clin Invest,1995,96(6):3009-3015.
[57]Busch N, Lammert F, Matern S. Biliary secretory immunoglobulin A is a major constituent of the new group of cholesterol crystal-binding proteins [J]. Gastroenterology,1998,115(1):129-138.
[58]Holzbach RT, Kibe A, Thiel E, et al. Biliary proteins:unique inhibitors of cholesterol crystal nucleation in human gallbladder bile [J]. J Clin Invest,1984, 73(1):35-45.
[59]Kibe A, Holzbach RT. Inhibition of cholesterol crystal formation by apolipo-proteins in supersaturated model bile [J]. Science,1984,255(4661):514-516.
[60]van Erpecum KJ, Portincasa P, Dohlu HM, et al. Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients [J].Hepatology, 2003,39(1):7-11.
[61]Konikoff FM, de la Porte PL, Laufer H, et al. Calcium and the anionic polypeptide fraction (APF) have opposing effects on cholesterol crystallization in model bile [J]. Journal of Hepatology,1997,27(4):707-715.
[62]Hunter GK, Hauschka PV, Poole AR, et al. Nucleation and inhibition of hydroxyl-apatite formation by mineralized tissue proteins [J]. Biochem J,1996,317(pt 1): 59-64.
[63]Hoyer JR, Asplin JR, Otvos L Jr. Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals [J]. Kidney Int,2001,60(1):77-82.
[64]Kleinman JG, Jeffrey A. Hughesb WJ. Osteopontin and Calcium Stone Formation [J]. Nephron Physiol,2004,98(2):43-47.
[65]Nakai A, Imano M, Takeyama Y, et al. An immunohistochemical study of osteopontin in hepatolithiasis [J]. J Hepatobiliary Pancreat Surg,2008,15 (6): 615-621.
[66]Ichikawa H, Imano M, Takeyama Y, et al. Involvement of osteopontin as a core protein in cholesterol gallstone formation [J]. J Hepatobiliary Pancreat Surg, 2009,16 (2):197-203.
[67]Xiao ZL, Amaral J, Biancani P, et al. Impaired cytoprotective function of muscle in human gallbladders with cholesterol stones [J]. Am J Physiol Gastrointest Liver Physiol,2005,288(3):G525-G532.
[68]Moschetta A, Stolk MF, Rehfeld JF, et al. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR [J]. Aliment Pharmacol Ther,2001,15(2):181-185.
[69]Sitzmann JV, Pitt HA, Steinborn PA, et al. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans [J]. Surg Gynecol Obstet,1990, 170(1):25-31.
[70]Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones:a parsimonious hypothesis [J]. Eur J Clin Invest,1996,26(5):343-352.
[71]Xu QW, Shaffer EA. The Potential Site of Impaired Gallbladder Contractility in an Animal Model of Cholesterol Gallstone Disease [J]. Gastroenterology, 1996,110(1):251-257.
[72]Chen Q, Amaral J, Oh S, et al. Gallbladder relaxation in patients with pigment and cholesterol stones [J]. Gastroenterology,1997,113(3):930-937.
[73]van Erpecum KJ, Wang DQ-H, Lammert F, et al. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice:soluble pronucleating proteins in gallbladder and hepatic biles [J]. J Hepatol,2001,35(4):444-451.
[74]Corradini SG, Elisei W, Giovannelli L, et al. Impaired human gallbladder lipid absorption incholesterol gallstone disease and its effect on cholesterol solubilityin bile [J]. Gastroenterology,2000,118(5):912-920.
[75]van Erpecum KJ, vanBerge-Henegouwen GP, Stolk MFJ, et al. Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects [J]. J Hepatol,1992,14(2-3):194-202.
[76]Everhart JE, Yeh F, Lee ET, et al. Prevalence of gallbladder disease in American Indian populations:findings from the Strong Heart Study [J]. Hepatology,2002, 35(6):1507-1512.
[77]Everhart JE, Khare M, Hill M, et al. Prevalence and ethnic differences in gallbladder disease in the United States [J]. Gastroenterology,1999,117(3): 632-639.
[78]Miquel JF, Covarrubias C, Villaroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris[J]. Gastroenterology,1998,115(4):937-946.
[79]Rosmorduc O, Hermelin B, Boelle PY, et al. ABCB4 gene mutation-associated cholelithiasis in adults [J]. Gastroenterology,2003,125(2):452-459.
[80]Lammert F, Wang DQ, Hillebrandt S, et al. Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice:a model for low phospholipid-associated cholelithiasis [J]. Hepatology,2004,39(1):117-128.
[81]Grunhage F, Acalovschi M, Tirziu S, et al. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol [J]. Hepatology,2007,46(3):793-801.
[82]Gylling H, Hallikainen M, Pihlajamaki J, et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity [J]. J Lipid Res,2004,45(9):1660-1665.
[83]Bertomeu A, Ros E, Zambon D et al. Apolipoprotein E polymorphism and gallstones [J]. Gastroenterology,1996,111(6):1603-1610.
[84]Amigo L, Quinones V, Mardones P, et al. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high cholesterol diet [J]. Gastroenterology,2000,118(4):772-779.
[85]Han T, Jiang Z, Suo G, et al. Apolipoprotein B-100 gene Xba Ⅰ polymorphism and cholesterol gallstone disease [J]. Clin Genet,2000,57(4):304-308.
[86]Wang DQ, Afdhal NH. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes [J]. Curr Gastroenterol Rep,2004,6(2):140-150.
[87]Lyons MA, Wittenburg H. Cholesterol Gallstone Susceptibility Loci:A mouse map, candidate gene evaluation, and guide to human Lith genes [J]. Gastroenterology,2006,131(6):1943-1970.
[88]Katsika D, Grjibovski A, Einarsson C, et al. Genetic and environmental influences on symptomatic gallstone disease:a Swedish study of 43,141 twin pairs [J]. Hepatology,2005,41(5):1138-1143.
[89]Kesaniemi YA, Koskenvuo M, Vuoristo M, et al. Biliary lipid composition in monozygotic and dizygotic pairs of twins [J]. Gut,1989,30(12):1750-1756.
[90]Shaffer EA. Epidemiology of gallbladder stone disease [J]. Best Pract Res Clin Gastroenterol,2006,20(6):981-996.
[91]Carey MC, Kwon RS, Maurer KJ, et al. State of the art gallstone research in the post-genomic era [M]// Adler G, Blum HE, Fuchs M, et al, eds. Gallstones: pathogenesis and treatment. Dordrecht:Kluser Academic Publishers.2004:207-224.
[2]Wang DQH, Afdhal NH. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes [J]. Curr Gastroenterol Rep,2004,6(2): 140-150.
[3]Everhart JE, Khare M, Hill M, et al. Prevalence and ethnic differences in gallbladder disease in the United States [J]. Gastroenterology,1999,117(3): 632-639.
[4]Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States [J]. Gastroenterology,2002,122(5):1500-1511.
[5]Hou L, Shu XO, Gao YT, et al. Anthropometric measurements, physical activity, and the risk of symptomatic gallstone disease in Chinese women [J]. Ann Epidemiol,2009,19(5):344-350.
[6]祝学光.胆石病基础研究：关于成核、氨肽酶等方面的临床实验研究[J].中华肝胆外科杂志,2004,10(11)：726-728.
[7]Wang HH, Portincasa P, Wang DQH. Overexpression of estrogen receptor alpha (ER alpha) induces gallbladder hypomotility during cholesterol gallstone formation in mice [J]. Gastroenterology,2007,132(4):A2.
[8]Wittenburg H, Lammert F. Genetic predisposition to gallbladder stones [J]. Semin Liver Dis,2007,27(1):109-121.
[9]Lee DK, Tarr PI, Haigh WG, et al. Bacterial DNA in mixed cholesterol gallstones [J]. Am J Gastroenterol,1999,94(12):3502-3506.
[10]Somjen G, Gilat T. Contribution of vesicular and micellar carriers to cholesterol transport in human bile [J]. J Lipid Res,1985,26(6):699-704.
[11]Halpern Z, Dudley M, Kibe A, et al. Rapid vesicle formation and aggregation in abnormal human bile [J]. Gastroenterology,1986,90(4):875-885.
[12]Liao XM, Wiedmann TS. Formation of cholesterol crystals at a mucin coated substrate [J]. Pharm Res,2006,23(10):2413-2416.
[13]项建斌,蔡端,张延龄,等.胆汁成核效应蛋白的分离纯化与成核活性比较[J].中华肝胆外科杂志,2004,10(7)：453-456.
[14]Busch N, Matiuck N, Sahlin S, et al. Inhibition and promotion of cholesterol crystallization by protein factors from normal human gallbladder bile [J]. J Lipid Res,1991,32(4):695-702.
[15]Lee SM, Lamont JT, Carey MC. Role of gallbladder mucus hypersecretion in the evolution of cholesterol fallstones [J]. J Clin Invest,1981,67(6):1712-1723.
[16]Dayan YB, Vilkin A, Niv Y. Gallbladder mucin plays a role in gallstone formation [J]. Eur J Intern Med,2004,15(7):411-414.
[17]Miquel JF, Nunez L, Amigo L, et al. Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile [J]. Gastroenterology,1998,114(5):1016-1023.
[18]陈雨强,张延龄,蔡端,等.胆汁刀豆凝集素A结合蛋白在胆固醇结石早期形成阶段的作用[J].中华实验外科杂志,1996,13(4)：199-200.
[19]励峰,蔡端,莫汉庆,等.ELISA法检测200kDa糖蛋白[J].中华消化杂志,1997,17(6)：333-335.
[20]Holzbach RT, Kibe A, Thiel E, et al. Biliary proteins:unique inhibitors of cholesterol crystal nucleation in human gallbladder bile [J]. J Clin Invest,1984, 73(1):35-45.
[21]Kibe A, Holzbach RT. Inhibition of cholesterol crystal formation by apolipo-proteins in supersaturated model bile [J]. Science,1984,255(4661):514-516.
[22]Secknus R, Darby GH, Chernosky A, et al. Apolipoprotein A-I in bile inhibitors cholesterol crystallization and modifies transcellular lipid transfer through cultured human gallbladder epithelial cells [J]. J Gastroenterol Hepatol,1999, 14(5):446-456.
[23]Mazzali M, Kipari T, Ophascharoensuk V, et al. Osteopontin-a molecule for all seasons [J]. QJM,2002,95(1):3-13.
[24]Gericke A, Qin C, Spevak L, et al. Importance of phosphorylation for osteopontin regulation of biomineralization [J]. Calcif Tissue Int,2005,77(1):45-54.
[25]Arafat HA, Wein AJ, Chacko S. Osteopontin gene expression and immunolocalization in the rabbit urinary tract [J]. J Urol,2002,167(2):746-752.
[26]Brown LF, Berse B, Van De Water L, et al. Expression and distribution of osteopontin in human tissues:widespread association with luminal epithelial surfaces [J]. Mol Biol Cell,1992,3(10):1169-1180.
[27]Butler WT. The nature and significance of osteopontin [J]. Connect Tissue Res, 1989,23(2):123-136.
[28]Denhardt DT, Guo X. Osteopontin:a protein with diverse functions [J].FASEB J, 1993,7(15):1475-1482.
[29]Xie YS, Sakatsume M, Nishi S, et al. Expression, roles, receptors, and regulation of osteopontin in the kidney [J]. Kidney Int,2001,60(5):1645-1657.
[30]Jeffrey AW, Richard JJ, Marrilda M, et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules [J]. J Am Soc Nephrol,2003,14(1):139-147.
[31]Watts RWE. Idiopathic urinary stone disease:possible polygenic aetiological factors [J]. QJM,2005,98(4):241-246.
[32]Hoyer JR. Uropontin in urinary calcium stone formation [J]. Miner Electrolyte Metab,1994,20(6):385-392.
[33]Hoyer JR, Asplin JR, Otvos L. Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals [J]. Kidney Int.2001,60(1):77-82.
[34]Lieske JC, Leonard R, Toback F. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions [J]. Am J Physiol, 1995,268(4):F604-612.
[35]Bing G, Takahiro Y, Atsushi O, et al. A polymorphism of the osteopontin gene is related to urinary calcium stones [J]. J Urology,2005,174(4 pt 1):1472-1476.
[36]Moore EW. Biliary calcium and gallstone [J]. Hepatology,1990,12(3 pt 2): S206-S214.
[37]Nakai K, Tasuma S, Ochi H, et al. Does bilirubin play a role in the pathogenesis of both cholesterol and pigment gallstone formation? Direct and indirect influence of bilirubin on bile lithogenecity [J]. Biochim Biophys Acta,2001, 1534(2-3):78-84.
[38]Sahai A, Malladi P, Melin-Aldana H, et al. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model [J]. Am J Physiol Gastrointest Liver Physiol,2004,287(1): G264-G273.
[39]Whitington PF, Malladi P, Melin-Aldana H, et al. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia [J]. Pediatr Res.2005,57(6):837-44.
[1]Hou L, Shu XO, Gao YT, et al. Anthropometric measurements, physical activity, and the risk of symptomatic gallstone disease in Chinese women [J]. Ann Epidemiol,2009,19(5):344-350.
[2]Cetta F, Lombardo F, Giubbolini M, et al. Classification of gallstones and epidemiologic studies [J]. DigDis Sci,1995,40(10):2189-2191.
[3]Cetta F, Lombardo F, Giubbolini M, et al. Quantity and location of stone compounds, not the mere presence in small amounts within the stone fabric, are important factors for the correct classification of the gallstones and a better knowledge of their pathogenesis [J]. Hepatology,1995,23(5):1285-1287.
[4]赵纪春,舒哗,程南生,等.胆囊结石中胆固醇代谢变化的实验研究[J].中国普通外科杂志,2000,9(2)：124-128.
[5]Moore EW. Biliary calcium and gallstones formation [J]. Hepatology,1990,12(3 pt2):S206-S214.
[6]Levy PF, Smith BF, LaMont JT, Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile [J]. Gastroenterology,1984,87 (2):270-275.
[7]Xiang JB, Cai D, Ma BJ, et al. Purification and characterization of 33.5 kDa vesicular protein in human bile [J]. World J Gastroenterol,2003,9(11): 2539-2543.
[8]Miquel JF, van der Putten J, Pimentel F, et al. Increased activity in the biliary Con A-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients [J]. Hepatology,2001,33(2):328-332.
[9]Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man [J]. J Clin Invset,1968,47(5):1043-1052.
[10]Wang DQH, Carey MC. Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles:identical pathways to corresponding model biles with three predominating sequences [J]. J Lipid Res, 1996,37(12):2539-2549.
[11]朱雷明,蔡端,张延龄。模拟胆汁体系中游离胆红素的热力学研究[J].外科理论与实践,1999,4(1)：13-17.
[12]Holan KR, Holzbach RT, Hermann HE, et al. Nucleation time:a key factor in the pathogenesis of cholesterol gallstone disease [J]. Gastroenterology,1979,77(4 pt 1):611-617.
[13]Yamashita Y, Tazuma S, Kajiyama G. Method for quantitative assessment of transformation of non-micellar cholesterol carriers in model bile systems [J]. J Gastroenterol Hepatol,1996,11(9):864-869.
[14]Busch N, Tokumo H, Holzbach RT. A sensitive method for determination of cholesterol growth using model solutions of supersaturated bile [J]. J Lipid Res, 1990,31(10):1903-1909.
[15]Denhardt DT, Guo X. Osteopontin:A protein with diverse functions [J]. FASEB J,1993,7(15):1475-1482.
[16]Qu H, Brown LF, Senger DR, et al. Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells [J]. J Histochem Cytochem, 1994,42(3):351-361.
[17]Yasui T, Fujita K, Hayashi Y, et al. Quantificantion of osteopontin in the urine of healthy and stone-forming men [J]. Urol Res,1999,27(4):225-230.
[18]Kibe A, Dudley MA, Halpern DZ, et al. Factors influencing cholesterol monohydrate crystal nucleation time in model systems of supersaturated bile [J]. J Lipid Res,1985,26(9):1102-1111.
[19]孙劲文,蔡端,马保金,等.综合模拟胆汁体系中未结合胆红素与胆固醇的溶解方式[J].肝胆胰外科杂志,2004,16(1)：23-25.
[20]Busch N, Matiuck N, Sahlin S, et al. Inhibition and promotion of cholesterol crystallization by protein fraction from normal human gallbladder bile [J]. J Lipid Res,1991,32(4):695-702.
[21]Carey MC, Small DM. The physical chemistry of cholesterol solubility in bile. Relation to gallstone formation and dissolution in man [J]. J Clin Invest,1978, 61(4):998-1026.
[22]Holzbach RT, Marsh M, Kwasnick RF, et al. Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man [J]. J Clin Invest, 1973,52(6):1467-1479.
[23]Mazer NA, Carey MC. Quasi-elastic lightscattering studies of aqueous biliary lipid systems.Cholesterol solubilization and precipitation in model bile solutions [J]. Biochemistry,1983,22(2):426-442.
[24]Somjen GJ, Gilat T. A non-micellar mode of cholesterol transport in human bile [J]. FEBS Lett,1983,156(2):265-268.
[25]Somjen GJ, Gilat T. Contribution of vesicular and meciller carriers to cholestrerol transport in human bile [J]. J Lipid Res,1985,26(6):699-704.
[26]Halpern Z, Dudley MA, Lynn MP, et al. Vesicle aggregation in model systems of supersaturated bile:relation to crystal nucleation and lipid composition of the vesicle phase [J]. J Lipid Res,1986,27(3):295-306.
[27]Moser AJ, Abedin MZ, Roslyn JJ. Increased biliary protein precedes gallstone formation [J]. Dig Dis Sci,1994,39(6):1313-1320.
[28]Oldberg A, Franzen A, Heinegard D. Cloning and se-quence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp Cell-binding sequence [J]. Proc Natl Acad Sci USA,1986,83(23):8819-8823.
[29]O'Young J, Chirico S, Al Tarhuni N, et al. Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals [J]. Cells Tissues Organs,2009,189(1-4):51-55.
[30]Kleinman JK, Wessona JA, Hughesb J. Osteopontin and Calcium Stone formation [J]. Nephron Physiol,2004,98(2):43-47.
[31]Nakai A, Imnao M, Takeyama Y, et al. An immunohistochemical study of osteopontin in hepatolithiasis [J]. J Hepatobiliary Pancreat Surg,2009,15(6): 615-621.
[32]Dixit M, Choudhuri G, Saxena R, et al. Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease [J]. Can J Gastroenterol,2007, 21(9):569-575.
[33]Ostrow JD. APF/CBP, an anionic polypeptide in bile and gallstones that may regulate calcium salt and cholesterol precipitation from bile [J]. Hepatology, 1992,16(6):1493-1496.
[34]Liaw L, Skinner MP, Raines EW, et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins:Role of αvβ3 in smooth muscle migration to osteopontin in vitro [J]. J Clin Invest,1995,95(2): 713-724.
[35]Konikoff FK, de la Porte PL, Laufer H, et al. Calcium and the anionic polypeptide fraction (APF) have opposing effects on cholesterol crystallization in model bile [J]. J Hepatol,1997,27(4):707-715.
[36]Lafont H, Domingo N, Groen A, et al. APF/CBP, the Small, Amphipathic, Anionic Protein(s) in Bile and Gallstones, Consists of Lipid-Binding and Calcium-Binding Forms [J]. Hepatology,1997,25(5):1054-1063.
[1]Holzbach RT, Kibe A, Thiel E, et al. Biliary proteins, unique inhibitors of cholesterol crystal nucleation in human gallbladder bile [J]. J Clin Invest,1984, 73(1):35-45.
[2]Sewell RB, Mao SJ, Kawamoto T, et al. Apolipoproteins of high, low, and very low density lipoproteins in human bile [J]. J Lipid Res,1983,24(4):391-401.
[3]Kibe A, Holzbach RT, LaRusso NF, et al. Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile [J]. Science,1984, 225(4661):514-516.
[4]Teramen K, Tazuma S, Ohya T, et al. Comparative effects on biliary concanavalin A-bound glycoproteins and calcium ionson cholesterol crystal nucleation and growth in model bile [J]. J gastroenterol,1995,30(4):500-507.
[5]傅培彬,张圣道,郑魁元,等.168例胆石化学成份分析[J].中华消化杂志,1983,3(3)：170-172.
[6]Strasberg SM, Harvey PRC, Hofmann AF. Bile sampling, processing and analysis in clinical-studies [J]. Hepatology,1990,12(3):S176-S182.
[7]Holan KR, Holzbach RT, Hermann RE, et al. Nucleation time:a key factor in the pathogenesis of cholesterol gallstone disease[J]. Gastroenterology,1979,77(4 pt 1):611-617.
[8]Carey MC. Critical tables for calculating the cholesterol saturation of native bile [J]. J Lipid Res,1978,19(8):945-955.
[9]Kibe A, Dudley MA, Halpern Z, et al. Factors affecting cholesterol monohydrate crystal nucleation time in model systems of supersaturated bile [J]. J Lipid Res, 1985,26(9):1102-1111.
[10]常连胜,冯陶,郭应禄,等.结石病人尿骨桥蛋白测定的临床意义[J].中华泌尿外科杂志,2000,21(12)：907-909.
[11]Kleinman JK, Wessona JA, Hughesb J. Osteopontin and Calcium Stone formation [J]. Nephron Physiol,2004,98(2):43-47.
[12]Moore EW. Biliary calcium and gallstone formation [J]. Hepatology,1990,12(3 pt2):S206-S214.
[13]Singh K, Deonarine D, Shanmugam V, et al. Calcium-binding properties of osteopontin derived from non-osteogenic sources [J]. J Biochem,1993,114(5): 702-727.
[14]Lafont H, Domingo N, Groen A, et al. APF/CBP, the Small, Amphipathic, Anionic Protein(s) in Bile and Gallstones, Consists of Lipid-Binding and Calcium-Binding Forms [J]. Hepatology,1997,25(5):1054-1063.
[15]Kaufman HS, Magnuson TH, Pitt HA, et al. The distribution of calcium salt precipitates in the core, periphery and shell of cholesterol, black pigment and brown pigment gallstones [J]. Hepatology,1994,19(5):1124-32.
[16]Liao XM, Wiedmann TS. Formation of cholesterol crystals at a mucin coated substrate [J]. Pharmaceutical Research,2006,23(10):2413-2416.
[17]van Erpecum KJ. Biliary lipids, water and cholesterol gallstones [J]. Biology of the Cell,2005,97(11):815-822.
[18]Halpern Z, Dudley M, Kibe A, et al. Rapid vesicle formation and aggregation in abnormal human bile [J]. Gastroenterology,1986,90(4):875-885.
[19]Wang DQH, Carey MC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile:influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing system [J]. J Lipid Res,1996,37(3):606-630.
[20]O'leary DP. Biliary cholesterol transport and the nucleation defect in cholesterol gallstone formation [J]. J Hepatol,1995,22(2):239-246.
[21]Abei M, Schwarzendrube J, Nuutinen H, et al. Cholesterol crystallization-promoters in human bile-comparative potencies of immunoglobulins, Alpha(1)-acid glycoprotein, phospholipase-C, and aminopeptidase-N [J]. J Lipid Res,1993, 34(7):1141-1148.
[22]Abei M, Nuutinen H, Kawczak P, et al. Identification of human biliary Alpha (1)-acid glycoprotein as a cholesterol crystallization promoter [J]. Gastroenterology,1994,106(1):231-238.
[23]Jungst D, Lang T, Ritter CV, et al. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones [J].1992, Hepatology, 15(5):804-808.
[24]Gollish SH, Burnstein MJ, Ilson RG, et al. Nucleation of cholesterol monohydrate crystals from hepatic and gallbladder bile of patients with cholesterolgallstones [J]. Gut,1983,24(9):836-844.
[25]Knyrim K, Vakil N. Bile composition, microspheroliths, antinucleating activity, and gallstone calcification [J]. Gastroenterology,1992,103(2):552-559.
[26]O'Young J, Chirico S, A1 Tarhuni N, et al. Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals [J]. Cells Tissues Organs,2009,189(1-4):51-55.
[1]Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease [J]. Lancet,2006,368(9531):230-239.
[2]Tuck AB, Hota C, Wilson SM, et al. Osteopontin induced migration of human mammary epit helial cells involves activation of EGF receptor and multiple signal t ransduction pat hways [J]. Oncogene,2003,22 (8):1198-1205.
[3]Marroquin CE, Downey L, Guo H, et al. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells [J]. Immunol Lett,2004,95(1):109-112.
[4]Ellen MG. Osteopontin:a bridge between bone and immune system [J]. J Clin Invest,2003,112 (2):147-149.
[5]傅培彬,张圣道,郑魁元,等.168例胆石化学成份分析[J].中华消化杂志,1983,3(3)： 170-172.
[6]Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent [J]. J Biol Chem,1951,193(1):265-275.
[7]Denhardt DT, Guo X. Osteopontin:A protein with diverse functions [J]. FASEB J,1993,7(15):1475-1482.
[8]Brown LF, Berse B, Van de Water L, et al. Expression and distribution of osteopontin in human tissues:widespread association with luminal epithelial surfaces [J]. Mol Biol Cell,1992,3(10):1169-1180.
[9]Qu H, Brown LF, Senger DR, et al. Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells [J]. J Histochem Cytochem, 1994,42(3):351-361.
[10]Liaw L, Skinner MP, Raines EW, et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins:Role of avB3 in smooth muscle migration to osteopontin in vitro [J]. J Clin Invest,1995,95(2): 713-724.
[11]Weber GF, Ashkar S, Glimcher MJ, et al. Receptor-ligand interaction between CD44 and osteopontin (ETA-1) [J]. Science,1996,271(5248):509-512.
[12]Chakraborty G, Jain S, Behera R, et al. The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis [J]. Curr Mol Med,2006,6 (8):819-830.
[13]Chellaiah MA, Biswas RS, Rittling SR, et al. Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts [J]. J Biol Chem,2003,278 (31):29086-29097.
[14]Denhardt D. Osteopontin expression correlates wit h melanoma invasion [J]. J Invest Dermatol,2005,124(5):16-18.
[15]Nakai A, Imano M, Takeyama Y, et al. An immunohistochemical study of osteopontin in hepatolithiasis [J]. J Hepatobiliary Pancreat Surg,2008,15(6): 615-621.
[16]Ichikawa H, Imano M, Takeyama Y, et al. Involvement of osteopontin as a core protein in cholesterol gallstone formation [J]. J Hepatobiliary Pancreat Surg, 2009,16(2):197-203.
[17]Farach-Carson MC, Xu Y. Microarray detection of gene expression changes induced by 1,25(OH)(2)D(3) and a Ca(2+) influx-activating analog in osteoblastic ROS 17/2.8 cells [J]. Steroids,2002,67(6):467-470.
[18]Dibya D, Arora N, Smith EA. Noninvasive measurements of integrin microclustering under altered membrane cholesterol levels [J]. Biophys J,2010, 99(3):853-861.
[19]Pankov R, Markovska T, Hazarosova R, et al. Cholesterol distribution in plasma membranes of betal integrin-expressing and beta1 integrin-deficient fibroblasts [J]. Arch Biochem Biophys,2005,442(2):160-168.
[20]Dray-Charier N, Paul A, Combettes L, et al. Regulation of Mucin Secretion in Human Gallbladder Epithelial Cells:Predominant Role of Calcium and Protein Kinase C [J]. Gastroenterology,1997,112(3):978-990.
[21]Shoda J, He BF, Tanaka N, et al. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit [J]. Hepatology,1995,21(5):1291-1302.
[22]Xiao ZL, Chen Q, Amaral J, et al. Defect of receptor-G protein coupling in human gallbladder with cholesterol stones [J]. Am J Physiol Gastrointest Liver Physiol,2000,278(2):G251-G258.
[23]Xiao ZL, Amaral J, Biancani P, et al. Impaired cytoprotective function of muscle in human gallbladders with cholesterol stones [J]. Am J Physiol Gastrointest Liver Physiol,2005,288(3):G525-G532.
[24]van Erpecum KJ, Venneman NG, Portincasa P, et al. Review article:agents affecting gallbladder motility-role in treatment and prevention of gallstones [J]. Aliment Pharmacol Ther,2000,14(S2):66-70.
[25]Moschetta A, Stolk MF, Rehfeld JF, et al. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR [J]. Aliment Pharmacol Ther,2001,15(2):181-185.
[26]Sitzmann JV, Pitt HA, Steinborn PA, et al. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans [J]. Surg Gynecol Obstet,1990, 170(1):25-31.
[27]Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones:a parsimonious hypothesis [J]. Eur J Clin Invest,1996,26(5):343-352.
[28]焦宛,张延龄,钟慈声.胆囊结石患者胆囊上皮细胞超微结构的图像学分析[J].上海医学,1994,17(7)：373-375.
[29]钱昌林,杨林,陈进宏,等.人胆囊组织蛋白质表达谱的建立[J].外科理论与实践,2010,15(1)：38-42.
[30]Kariuki SN, Moore JG, Kirou KA, et al. Age-and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus [J]. Genes Immun,2009,10(5):487-494.
[31]Schack L, Lange A, Kelsen J, et al. Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas [J]. J Dairy Sci, 2009,92(11):5378-5385.
[32]Tsuji H, Tohru U, Hirotsugu U, et al. Urinary concentration of osteopontin and association with urinary supersaturation and crystal formation [J]. Int J Urol, 2007,14(7):630-634.
[33]Nagatomo T, Ohga S, Takada H, et al. Microarray analysis of human milk cells: persistent high expression of osteopontin during the lactation period [J]. Clin Exp Immunol,2004,138(1):47-53.
[1]Hay DW, Carey MC. Pathophysiology and pathogenesis of cholesterol gallstone formation [J]. Semin Liver Dis,1990,10(3):159-170.
[2]Hofmann AF. Pathogenesis of cholesterol gallstones [J]. J Clin Gastroenterol, 1988,10(S2):S1-S11.
[3]Marschall HU, Einarsson C. Gallstone disease [J]. Journal of Internal Medicine, 2007,261(6):529-542.
[4]Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States [J]. Gastroenterology,2002,122(5):1500-1511.
[5]Portincasa P, Moschetta A, Mazzone A, et al. Water handling and aquaporins in bile formation:recent advances and research trends [J]. J Hepatol,2003,39(5): 864-874.
[6]Katsika D, Grjibovski A, Einarsson C, et al. Genetic and environmental influences on symptomatic gallstone disease:a Swedish study of 43,141 twin pairs [J]. Hepatology,2005,41(5):1138-1143.
[7]Brown LF, Berse B, Van de Water L, et al. Expression and distribution of osteopontin in human tissues:widespread association with luminal epithelial surfaces [J]. Mol Biol Cell,1992,3(10):1169-1180.
[8]Qu H, Brown LF, Senger DR, et al. Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells [J]. J Histochem Cytochem, 1994,42(3):351-361.
[9]Gotoh M, Sakamoto M, Kanetaka K, et al. Overexpression of osteopontin in hepatocellular carcinoma [J]. Pathol Int,2002,52(1):19-24.
[10]Reihner E, Stahlberg D. Lithogenic diet and gallstone formation in mice: integrated response of activities of regulatory enzymes in hepatic cholesterol metabolism [J]. Br J Nutr,1996,76(5):765-772.
[11]Gosiewska A, Wilson S, Kwon D, et al. Evidence for an in vivo role of insulin-like growth factor-binding protein-1 and -2 as inhibitors of collagen gene expression in vitamin C-deficient and fasted guinea pigs [J]. Endocrinology, 1994,134(3):1329-1339.
[12]Shiesh SC, Chen CY, Lin XZ, et al. Melatonin Prevents Pigment Gallstone Formation Induced by Bile Duct Ligation in Guinea Pigs [J]. Hepatology,2000, 32(3):455-460.
[13]Mahmoodian F, Gosiewska A, Peterkofsky B. Regulation and Properties of Bone Alkaline Phosphatase during Vitamin C Deficiency in Guinea Pigs [J]. Arch Biochem Biophys,1996,336(1):86-96.
[14]周文江,杨幼明,方玉梅,等.豚鼠胆囊胆固醇结石模型的建立[J].中国实验动物学杂志,1999,9(4)：198-201.
[15]韩天权,张圣道.胆石病流行病学研究的现状和发展[J].胃肠病学,2003,8(3)：166-168.
[16]Mendez-Sanchez N, Zamora-Valdes D, Chavez-Tapia NC, et al. Role of diet in cholesterol gallstone formation [J]. Clin Chim Acta,2007,376 (1-2):1-8.
[17]Pacchioni M, Nicoletti C, Caminiti M, et al. Association of obesity and type II diabetes mellitus as a risk factor for gallstones [J]. Dig Dis Sci,2000,45(10): 2002-2006.
[18]Dam H. Determinants of cholesterol cholelithiasis in man and animals [J]. Am J Med,1971,51(5):596-613.
[19]Holzbach RT. Animal models of cholesterol gallstone disease [J]. Hepatology, 1984,4(5):S191-S198.
[20]Lofland HB. Animal models of human disease:cholelithiasis [J]. Am J Pathol, 1975,79(3):619-622.
[21]Gurll N, DenBesten L. Animal models of human cholesterol gallstone disease:a review [J]. Lab Anim Sci,1978,28(4):428-432.
[22]别平,黄志强,韩本立,等.高胆固醇饲料对豚鼠胆囊组织分泌糖蛋白的影响.第三军医大学学报,1999,21(1)：48-50.
[23]李均乐,田立新.绞股蓝预防豚鼠胆囊胆固醇结石形成[J].中华肝胆外科杂志,2002,8(10)：609-610.
[24]Jenkins SA. Hypovitaminosis C and cholelithiasis in guinea pigs [J]. Biochem Biophys Res Commun,1977,77(3):1030-1035.
[25]Amigo L, Quinones V, Mardones P, et al. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet [J]. Gastroenterology,2000,118 (4):772-779.
[26]Brotschi EA, Pattavino J, Williams LF. Intrinsic nerves affect gallbladder contraction in the guinea pig [J]. Gastroenterology,1990,99(3):826-830.
[27]肖勇,余保平,吴志轩,等.胆囊收缩素对胆固醇结石豚鼠离体胆囊肌条的影响[J].世界华人消化杂志,2008,16(20)：2280-2284.
[28]Marin JJ, Serrano MA, Mirmy El, et al. Bile acid transport by basal membrance vesicles of human term placental trophoblast [J]. Gastroenterology,1990,99(5): 1431-1433.
[29]Gerloff T, Stieger B, Hagenbuch B, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver [J]. J Biol Chem,1998, 273(16):10046-10050.
[30]Acalovschi M. Cholesterol gallstones:from epidemiology to prevention [J]. Postgrad Med J,2001,77(906):221-229.
[31]Lammert F, Sauerbruch T. Mechanisms of disease:the genetic epidemiology of gallbladder stones [J]. Nat Clin Pract Gastroenterol Hepatol,2005,2(9): 423-433.
[32]姜皓,施维锦.熊胆预防豚鼠胆囊胆固醇结石的实验研究[J].上海医学,2000,23(7)：417-419.
[33]Dayan YB, Vilkin A, Niv Y. Gallbladder mucin plays a role in gallstone formation [J]. Eur J Intern Med,2004,15(7):411-414.
[34]Abei M, Nuutinen H, Kawczak P, et al. Identification of human biliary Alpha(1)-acid glycoprotein as a cholesterol crystallization promoter [J]. Gastroenterology,1994,106(1):231-238
[35]Ohya T, Schwarzendrube J, Busch N, et al. Isolation of a human biliary glycoprotein inhibitor of cholesterol crystallization [J]. Gastroenterology,1993, 104(2):527-538.
[36]Busch N, Holzbach RT. Crystal growth-inhibiting proteins in bile [J]. Hepatology, 1990,12(3):S195-S198.
[1]韩天权,张圣道.胆石病流行病学研究的现状和发展[J].胃肠病学,2003,8(3)：166-168.
[2]Misciagna G, Centonze S, Leoci C, et al. Diet, physical activity, and gallstones-a population-based, case-control study in southern Italy [J]. Am J Clin Nut,1999, 69(1):120-126.
[3]Hou L, Shu XO, Gao YT, et al. Anthropometric measurements, physical activity, and the risk of symptomatic gallstone disease in Chinese women [J]. Ann Epidemiol,2009,19(5):344-350
[4]Groen AK, Noordam C, Drapers JA, et al. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile:role in the pathogenesis of gallstone disease [J]. Hepatology,1990, 11(4):525-533.
[5]Zhou H, Chen B, Li RX, et al. Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach [J]. Rapid Communications in Mass Spectrometry,2005,19(23):3569-3578
[6]Miquel JF, Putten J, Pimentel F, et al. Increased activity in the biliary ConA-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients [J]. Hepatology,2001,33(2):328-332.
[7]Lammert F, Sauerbruch T. Mechanisms of disease:the genetic epidemiology of gallbladder stones [J]. Nat Clin Pract Gastroenterol Hepatol,2005,2(9): 423-433.
[8]Paumgartner G, Sauerbruch T. Gallstones:pathogenesis [J]. Lancet,1991, 338(8775):1117-1121.
[9]Small DM. Role of ABC transporters in secretion of cholesterol from liver into bile [J]. Proc Natl Acad Sci USA,2003,100(1):4-6.
[10]Robins SJ, Fasulo JM, Lessard PD, et al, Hepatic cholesterol synthesis and the secretion of newly synthesized cholesterol in bile [J]. Biochem J,1993,289(pt1): 41-44.
[11]Groen AK, Bloks VW, Bandsma RH, et al. Hepatobiliary cholesterol transport is not impaired in Abcal-null mice lacking HDL [J]. J Clin Invest,2001,108(6): 843-850.
[12]Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver Ⅹ receptors alpha and beta [J]. J Biol Chem,2002,277(21):18793-18800.
[13]Moschetta A, Bookout AL, Mangelsdorf DJ. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model [J]. Nat Med,2004,10(12): 1352-1358.
[14]Carey MC, Small DM. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man [J]. J Clin Invest, 1978,61(4):998-1026.
[15]Holzbach RT, Marsh M, Olsezwski M, et al. Cholesterol solubility in bile: evidence that supersaturated bile is frequent in healthy man [J]. J Clin Invest, 1973,52(6):1467-1479.
[16]Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man [J]. J Clin Invest,1968,47(5):1043-1052.
[17]Gustafsson U, Sahlin S, Einarsson C. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstonefree subjects:deoxycholic acid does not contribute to formation of cholesterol gallstones [J]. Eur J Clin Invest, 2000,30(12):1099-1106.
[18]Miquel JF, Nunez L, Amigo L, et al. Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile [J]. Gastroenterology,1998,114(5):1016-1023.
[19]Somjen GJ, Gilat T. A non-micellar mode of cholesterol transport in human bile [J]. FEBS Lett,1983,156(2):265-268.
[20]Somjen GJ, Gilat T. Contribution of vesicular and meciller carriers to cholestrerol transport in human bile [J]. J Lipid Res,1985,26(6):699-704.
[21]Halpern Z, Dudley MA, Lynn MP, et al. Vesicle aggregation in model systems of supersaturated bile:relation to crystal nucleation and lipid composition of the vesicle phase [J]. J Lipid Res,1986,27(3):295-306
[22]Halpern Z, Dudley MA, Kibe A, et al. Rapid vesicle formation and aggregation in abnormal human biles. A time-lapse video-enhanced contrast microscopy study [J]. Gastroenterology,1986,90(4):875-885.
[23]Cohen DE, Carey MC. Physical chemistry of biliary lipids during bile formation [J]. Hepatology,1990,12(3 pt 2):S143-S148.
[24]Eckhardt ER, Van de Heijning BJM, Van Erpecum KJ, et al. Quantitation of cholesterol carrying particles in human gallbladder bile [J]. J Lipid Res,1998, 39(3):594-603.
[25]Harvey PR, Somjen G, Gilat T, et al. Vesicular cholesterol in bile. Relationship to protein concentration and nucleation time [J]. Biochim Biophys Acta,1988, 958(1):10-8.
[26]Holan KR, Holzbach RT, Hermann HE, et al. Nucleation time:a key factor in the pathogenesis of cholesterol gallstone disease [J]. Gastroenterology,1979,77(4 pt 1):611-617.
[27]Holzbach RT. Recent progress in understanding cholesterol crystal nucleation as a precursor to human gallstone formation [J]. Hepatology,1986,6(6):1403-1406.
[28]Afdhal NH, Niu N, Gantz D, et al. Bovine gallbladder mucin accelerates cholesterol monohydrate crystal growth in model bile [J]. Gastroenterology, 1993,104(5):1515-1523.
[29]Busch N, Tokumo H, Holzbach RT. A sensitive method for determination of cholesterol growth using model solutions of supersaturated bile [J]. J Lipid Res, 1990,31(10):1903-1909.
[30]Afdhal NH, Niu N, Nunes DP, et al. Mucin-vesicle interactions in model bile: evidence for vesicle aggregation and fusion before cholesterol crystal formation [J]. Hepatology,1995,22(3):856-865.
[31]Smith BE. Human gallbladder mucin binds biliary lipids and promotes cholesterol nucleation in model bile [J]. J Lipid Res,1987,28(9):1088-1097.
[32]Gallinger S, Taylor RD, Harvey PR, et al. Effect of mucous glycoprotein on nucleation time of human bile [J]. Gastroenterology,1985,89(3):648-658.
[33]Nuutinen H, Corradini SG, Jungst D, et al. Correalation between biliary α1-acid glycoprotein concentration and cholesterol crystal nucleation time in gallstone disease [J]. Dig Dis Sci,1995,40(6):1174-1178.
[34]Groen AK, Ottenhoff R, Jansen PL, et al. Effect of cholesterol nucleation promoting activity on cholesterol solubilization in model bile [J]. J Lipid Res, 1989,30(1):51-58.
[35]Upadhya GA, Harvey PR, Strasberg SM. Effect of human biliary immunoglo-bulins on the nucleation of cholesterol [J]. J Biol Chem,1993,268(7):5193-5200.
[36]Nakeeb SA, Barnes KD, Lillemoe HA, et al. Immunoglobulins in gallstone pathogenesis:A systemic or a local phenomenon [J]? Gastroenterology,1995, 108(4):A1092.
[37]Abei M, Schwarzendrube J, Nuutinen H, et al. Cholesterol crystallization-promoters in human bile:comparative potencies of immunoglobulins, alpha 1-acid glycoprotein, phospholipase C, and aminopeptidase N1 [J]. J Lipid Res, 1993,34 (7):1141-1148.
[38]Harvey PR, Upadhya GA, Strasberg SM. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones [J]. J Biol Chem,1991,266(21):13996-14003.
[39]Pattinson NR. Identification of a phosphatidylcholine active phospolipase C in human gallbladder bile [J]. Biochem Biophys Res Commun,1988,150(2): 890-896.
[40]Pattinson NR, Willis KE. Effect of phospholipase C on cholesterol solubilization in model bile. A concanavalin Abinding nucleation-promoting factor from human gallbladder bile [J]. Gastroenterology,1991,101(5):1339-1344.
[41]Halpern Z, Goldman G, Peled Y, et al. Free fatty acids have nucleating effects in model biles [J]. Liver,1992,12(3):107-111.
[42]Sunami Y, Tazuma S, Chayama K, et al. Is a role of phospholipase A2 in cholesterol gallstone formation phospholipid species-dependent [J]? Biochim Biophys Acta,2001,1532 (1-2):51-59.
[43]Nakayama F, Johnston CG. Fractionation of bile lipids with silicic acid and column chromatography [J]. J Lab Clin Med,1962,59(12):364-370.
[44]Halpern Z, Moshkowitz M, Laufer H, et al. Effect of phospholipids and their molecular species on cholesterol solubility and nucleation in human and model biles [J]. Gut,1993,34 (1):110-115.
[45]Offner GD, Gong D, Afdhal NH. Identification of a 130-kilodalton human biliary Concanavalin-A binding protein as aminopeptidase N [J]. Gastroenterology, 1994,106(3):755-762.
[46]Xiang JB, Cai D, Ma BJ,et al. Purification and characterization of 33.5 kDa vesicular protein in human bile [J]. World J Gastroenterol,2003,9 (11):2539-2543.
[47]张殿彩,项建斌,蔡端,王丽影,查锡良.胆汁泡相与微胶粒相的蛋白质表达谱对比观察[J].中华医学杂志,2008,88(46)：3298-3301.
[48]Schuber F, Hong K, Duzgunes N, et al. Polyamines as modulators of membrane fusion:aggregation and fusion of liposomes [J]. Biochemistry,1983,22 (26): 6134-6140.
[49]Konikoff F, Goldman G, Halpern Z, et al. Polyamines--potential nucleating factors in bile [J]. Liver,1990,10 (3):173-176.
[50]Moore E. The Role of Calcium in the Pathogenesis of Gallstones:Ca2+ Electrode Studies of Model Bile Salt Solutions and Other Biologic Systems With an Hypothesis on Structural Requirements for Ca++ Binding to Proteins and Bile Acids [J]. Hepatology,1984,4(5):S228-S243.
[51]Strichartz SD, Abedin MZ, Abdou MS, et al. Increased biliary calcium in cholesterol gallstone formation [J]. Am J Surg,1988,155 (1):131-137.
[52]de la Porte PL, Domingo N, van Wijland M, et al. Distinct immuno-localization of mucin and other biliary proteins in human cholesterol gallstones [J]. J Hepatol, 1996,25(3):339-348.
[53]Lafont H, Domingo N, Groen A, et al. APF/CBP, the Small, Amphipathic, Anionic Protein(s) in Bile and Gallstones, Consists of Lipid-Binding and Calcium-Binding Forms[J]. Hepatology,1997,25(5):1054-1063.
[54]Moore EW. Biliary Calcium and Gallstone Formation [J]. Hepatolgy,1990,12(3): S206-S213.
[55]Ohya T, Schwarzendrube J, Busch N, et al. Isolation of a human biliary glycoprotein inhibitor of cholesterol crystallization [J]. Gastroenterology,1993, 104(2):527-538.
[56]Busch N, Lammert F, Marschall HU, et al. A new subgroup of lectin-bound biliary proteins binds to cholesterol crystals, modifies crystal morphology, and inhibits cholesterol crystallization [J]. J Clin Invest,1995,96(6):3009-3015.
[57]Busch N, Lammert F, Matern S. Biliary secretory immunoglobulin A is a major constituent of the new group of cholesterol crystal-binding proteins [J]. Gastroenterology,1998,115(1):129-138.
[58]Holzbach RT, Kibe A, Thiel E, et al. Biliary proteins:unique inhibitors of cholesterol crystal nucleation in human gallbladder bile [J]. J Clin Invest,1984, 73(1):35-45.
[59]Kibe A, Holzbach RT. Inhibition of cholesterol crystal formation by apolipo-proteins in supersaturated model bile [J]. Science,1984,255(4661):514-516.
[60]van Erpecum KJ, Portincasa P, Dohlu HM, et al. Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients [J].Hepatology, 2003,39(1):7-11.
[61]Konikoff FM, de la Porte PL, Laufer H, et al. Calcium and the anionic polypeptide fraction (APF) have opposing effects on cholesterol crystallization in model bile [J]. Journal of Hepatology,1997,27(4):707-715.
[62]Hunter GK, Hauschka PV, Poole AR, et al. Nucleation and inhibition of hydroxyl-apatite formation by mineralized tissue proteins [J]. Biochem J,1996,317(pt 1): 59-64.
[63]Hoyer JR, Asplin JR, Otvos L Jr. Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals [J]. Kidney Int,2001,60(1):77-82.
[64]Kleinman JG, Jeffrey A. Hughesb WJ. Osteopontin and Calcium Stone Formation [J]. Nephron Physiol,2004,98(2):43-47.
[65]Nakai A, Imano M, Takeyama Y, et al. An immunohistochemical study of osteopontin in hepatolithiasis [J]. J Hepatobiliary Pancreat Surg,2008,15 (6): 615-621.
[66]Ichikawa H, Imano M, Takeyama Y, et al. Involvement of osteopontin as a core protein in cholesterol gallstone formation [J]. J Hepatobiliary Pancreat Surg, 2009,16 (2):197-203.
[67]Xiao ZL, Amaral J, Biancani P, et al. Impaired cytoprotective function of muscle in human gallbladders with cholesterol stones [J]. Am J Physiol Gastrointest Liver Physiol,2005,288(3):G525-G532.
[68]Moschetta A, Stolk MF, Rehfeld JF, et al. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR [J]. Aliment Pharmacol Ther,2001,15(2):181-185.
[69]Sitzmann JV, Pitt HA, Steinborn PA, et al. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans [J]. Surg Gynecol Obstet,1990, 170(1):25-31.
[70]Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones:a parsimonious hypothesis [J]. Eur J Clin Invest,1996,26(5):343-352.
[71]Xu QW, Shaffer EA. The Potential Site of Impaired Gallbladder Contractility in an Animal Model of Cholesterol Gallstone Disease [J]. Gastroenterology, 1996,110(1):251-257.
[72]Chen Q, Amaral J, Oh S, et al. Gallbladder relaxation in patients with pigment and cholesterol stones [J]. Gastroenterology,1997,113(3):930-937.
[73]van Erpecum KJ, Wang DQ-H, Lammert F, et al. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice:soluble pronucleating proteins in gallbladder and hepatic biles [J]. J Hepatol,2001,35(4):444-451.
[74]Corradini SG, Elisei W, Giovannelli L, et al. Impaired human gallbladder lipid absorption incholesterol gallstone disease and its effect on cholesterol solubilityin bile [J]. Gastroenterology,2000,118(5):912-920.
[75]van Erpecum KJ, vanBerge-Henegouwen GP, Stolk MFJ, et al. Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects [J]. J Hepatol,1992,14(2-3):194-202.
[76]Everhart JE, Yeh F, Lee ET, et al. Prevalence of gallbladder disease in American Indian populations:findings from the Strong Heart Study [J]. Hepatology,2002, 35(6):1507-1512.
[77]Everhart JE, Khare M, Hill M, et al. Prevalence and ethnic differences in gallbladder disease in the United States [J]. Gastroenterology,1999,117(3): 632-639.
[78]Miquel JF, Covarrubias C, Villaroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris[J]. Gastroenterology,1998,115(4):937-946.
[79]Rosmorduc O, Hermelin B, Boelle PY, et al. ABCB4 gene mutation-associated cholelithiasis in adults [J]. Gastroenterology,2003,125(2):452-459.
[80]Lammert F, Wang DQ, Hillebrandt S, et al. Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice:a model for low phospholipid-associated cholelithiasis [J]. Hepatology,2004,39(1):117-128.
[81]Grunhage F, Acalovschi M, Tirziu S, et al. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol [J]. Hepatology,2007,46(3):793-801.
[82]Gylling H, Hallikainen M, Pihlajamaki J, et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity [J]. J Lipid Res,2004,45(9):1660-1665.
[83]Bertomeu A, Ros E, Zambon D et al. Apolipoprotein E polymorphism and gallstones [J]. Gastroenterology,1996,111(6):1603-1610.
[84]Amigo L, Quinones V, Mardones P, et al. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high cholesterol diet [J]. Gastroenterology,2000,118(4):772-779.
[85]Han T, Jiang Z, Suo G, et al. Apolipoprotein B-100 gene Xba Ⅰ polymorphism and cholesterol gallstone disease [J]. Clin Genet,2000,57(4):304-308.
[86]Wang DQ, Afdhal NH. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes [J]. Curr Gastroenterol Rep,2004,6(2):140-150.
[87]Lyons MA, Wittenburg H. Cholesterol Gallstone Susceptibility Loci:A mouse map, candidate gene evaluation, and guide to human Lith genes [J]. Gastroenterology,2006,131(6):1943-1970.
[88]Katsika D, Grjibovski A, Einarsson C, et al. Genetic and environmental influences on symptomatic gallstone disease:a Swedish study of 43,141 twin pairs [J]. Hepatology,2005,41(5):1138-1143.
[89]Kesaniemi YA, Koskenvuo M, Vuoristo M, et al. Biliary lipid composition in monozygotic and dizygotic pairs of twins [J]. Gut,1989,30(12):1750-1756.
[90]Shaffer EA. Epidemiology of gallbladder stone disease [J]. Best Pract Res Clin Gastroenterol,2006,20(6):981-996.
[91]Carey MC, Kwon RS, Maurer KJ, et al. State of the art gallstone research in the post-genomic era [M]// Adler G, Blum HE, Fuchs M, et al, eds. Gallstones: pathogenesis and treatment. Dordrecht:Kluser Academic Publishers.2004:207-224.